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Zusammenfassung 
Typ-2-Diabetes mellitus (T2DM) ist die häufigste und gleichzeitig folgen-
schwerste Stoffwechselerkrankung weltweit. Neue Strategien zur Behandlung 
von T2DM und den damit verbundenen schwerwiegenden Folgeerkrankungen 
sowie die Entwicklung einer optimalen Medikation für alle Patienten sind daher 
sowohl in der akademischen Forschung, als auch in der pharmazeutischen In-
dustrie eine wichtige Thematik. Die vorliegende Promotionsarbeit zeigt die Etab-
lierung der Mikroelektrodenarray (MEA)-Technologie als neue und innovative 
Methode für die funktionale Untersuchung der in der Beta-Zelle entstehenden 
Veränderungen während der Entstehung von T2DM. Pfeiffer et al konnte erstma-
lig zeigen, dass die elektrische Aktivität von isolierten intakten Langerhans-Inseln 
reproduzierbar auf planaren Mikroelektroden extrazellulär gemessen werden 
kann (Pfeiffer et al., 2011). Die Ergebnisse der Messungen mit der MEA-Techno-
logie sind qualitativ vergleichbar mit den Ergebnissen, die mit den klassischen 
elektrophysiologischen Techniken, wie zum Beispiel der patch-clamp Technik  
oder der intrazellulären Mikroelektrodentechnik gemessen wurden (Pfeiffer et al., 
2011). Ferner habe ich zum ersten Mal eine Langerhans-Insel-Kultur auf Mikro-
elektroden entwickelt, mit der die Langerhans-Inseln ex vivo über einen Zeitraum 
von über einem Monat kultiviert werden konnten. Über die gesamte Zeit konnte 
die elektrische Aktivität stabil aufrechterhalten werden (Schönecker et al., 2014). 
Pathophysiologische Parameter, die die Entstehung von Diabetes begünstigen 
bzw. den Krankheitsverlauf beschleunigen, wie bspw. Überernährung und Bewe-
gungsmangel, schädigen die Langerhans-Inseln durch eine vermehrte Generie-
rung von u.a. reaktiven Sauerstoffspezies (ROS). Ich konnte durch Applikation 
von Wasserstoffperoxid (H2O2) oxidativen Stress auslösen, der einen signifikan-
ten Effekt auf die elektrische Aktivität der Beta-Zellen hatte und der durch die 
Applikation von dem Antioxidans Tempol aufgehoben werden konnte. Die Ergeb-
nisse dieser Studie belegen, dass die Gabe von antioxidativ wirkenden Substan-
zen, den verheerenden, durch ROS-ausgelösten Dysfunktionen entgegen wirken 
kann (Schönecker et al., 2014). In einem weiteren Teilprojekt der vorliegenden 
Arbeit konnte ich erstmalig elektrophysiologische Messungen mit humanen 
Langerhans-Inseln auf MEAs durchführen (Schönecker et al., 2015). Die durch 
das BMBF-Programm KMU Innovativ (Biotechnolgie-BioChance, #0316162B) 
geförderte Entwicklung des auf der MEA-Technologie basierenden BetaScreen-
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Geräts ermöglicht erstmals parallelisierte, semiautomatische Messungen von in-
takten Langerhans-Inseln. Das gegenwärtige Layout ermöglicht simultane Mes-
sungen von bis zu 25 Langerhans-Inseln, was den Durchsatz der akuten Mes-
sungen um den Faktor 25 erhöht. Der Einsatz des BetaScreen-Geräts ist nicht 
nur auf murine Langerhans-Inseln limitiert, sondern kann auch für die Messung 
elektrischer Aktivität humaner Langerhans-Inseln verwendet werden. Somit 
konnte die MEA-Technologie als neue und innovative Methode für die Untersu-
chung von humanen und murinen Langerhans-Inseln etabliert werden. 
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Summary 
Type-2 diabetes mellitus (T2DM) is a tremendous health problem worldwide. The 
present work demonstrates that the microelectrode array (MEA) technique is an 
excellent tool to study in vitro the molecular basis of functional changes in beta-
cells during the development of T2DM. I have provided the “proof-of-principle” 
that electrical activity can be reproducibly recorded using intact single islets and 
extracellular electrode arrays. The results revealed with the MEA technology are 
comparable to results obtained with traditional electrophysiological techniques, 
like e.g. the patch clamp technique or recordings with intracellular electrodes 
(Pfeiffer et al., 2011). Moreover, I established an in vitro model that allows for the 
first time long-term investigations of beta-cell function through repetitive electro-
physiological recordings of the same culture using the MEA technology 
(Schönecker et al., 2014). Further, I have shown that the application of oxidative 
stress which is crucial in the development of T2DM has a strong effect on the 
electrical behaviour of the single islets in vitro and that a SOD mimetic protects 
beta-cells against acute oxidative stress demonstrating the central role of SOD 
as an antioxidant defence mechanism within pancreatic islets (Schönecker et al., 
2014). The next fundamental achievement was to show for the first time that the 
MEA technique allows measurements of electrical activity of islets isolated from 
human biopsies. Human islets exhibit glucose-dependent electrical activity and 
the electrical activity was increased by tolbutamide and inhibited by diazoxide. 
The Na+ channel inhibitor tetrodotoxin markedly reduced electrical activity in hu-
man islets, but does not affect electrical activity of mouse islets (Schönecker et 
al., 2015). Within the scope of the BMBF-program KMU innovative (Biotechnol-
gie-BioChance, #0316162B) and in cooperation with the company Multi Channel 
Systems (MCS) this study presents for the first time the development of the Be-
taScreen device which allows to record semi automatically from up to 25 islets 
simultaneously. Importantly, the throughput of the acute recordings is now in-
creased by a factor of 25 and paves the way for pharmaceutical medium-through-
put drug screenings. Furthermore, I could show that the BetaScreen device is 
also suitable to record electrical activity from human islets. 
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Personal Contribution 
The goal of my PhD study was to establish the MEA-technology as a new tool for 
the investigation of whole intact islets of Langerhans and to find a new strategy 
to protect the islets against diabetes inducing stress factors. I could show for the 
first time that oscillatory activity can be reproducibly recorded via the MEA tech-
nology. Moreover, I developed and established for the first time an in vitro model 
that allows long-term investigations of beta-cell physiology on top of MEA elec-
trodes. Another fundamental achievement was that I was the first who could rec-
ord electrical activity of isolated human islets on extracellular electrodes. I was 
responsible for the biological part of the development of the BetaScreen device 
which includes all test recordings with primary cells and improvements of the re-
cordings assay. The data analysis and scientific interpretation of all electrical sig-
nals recorded from islets of Langerhans throughout the entire PhD study was 
carried out in agreement with my supervisors. 
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1 General Introduction 
The reason why islets of Langerhans obtain a remarkably amount of considera-
tion is due to their ability to produce and secrete the body’s only hormone which 
is able to lower blood glucose concentration. The impairment of a proper insulin 
secretion can result in several devastating diseases, e.g. diabetes mellitus or 
congenital hyperinsulinism (CHI). Furthermore it is a matter of fact that especially 
Type-2 diabetes mellitus (T2DM), the most abundant endocrine disease, is an 
increasing health problem worldwide which has reached epidemic levels. The 
growing prevalence underlines the importance to further understand the physiol-
ogy and pathophysiology of these fascinating islets. 
1.1 Islets of Langerhans 
The pancreas is an unpaired glandular organ which combines two main functions 
1) a digestive function and 2) an endocrine function. The digestive function com-
prise the secretion of pancreatic juice containing digestive enzymes and bicar-
bonate directly into the small intestine. These digestive enzymes are responsible 
for the breakdown of lipids, proteins and carbohydrates. The endocrine function 
is to secrete important hormones, including insulin, glucagon, somatostatin, and 
pancreatic polypeptide into the blood stream. The islets of Langerhans, small mi-
cro-organs that consist of different cell types, are responsible for the secretion of 
these hormons. The islets of Langerhans lie scattered throughout the pancreas.  
1.1.1 Anatomy of the islets of Langerhans 
The anatomical nomenclature was established by Edouard Laguesse (1861-
1927), the first who found out that they are involved in endocrine secretion. He 
called them islets of Langerhans after Paul Langerhans, who was the first de-
scriptor of these micro-organs (Langerhans 1869). The average diameter of a 
human islet is 140 µm (Hellman, Hellerström, 1969). They are highly vascularised 
and are surrounded by a collagen capsule (Hughes et al., 2006). The human 
pancreas contains approximately 1 million islets (Hellman, 1959) which is about 
1 to 2 % of the pancreatic cell mass. The islets comprise several different cell 
types, the most common ones are the insulin secreting beta-cells (up to 50 % in 
humans islets), glucagon producing alpha-cells (35-40 %), and the somatostatin 
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secreting delta-cells (10-15 %) (Cabrera et al., 2006). The secreted hormones 
leave the islets via small capillaries into the portal vein. 
1.2 The physiological function of ion channels in beta-cells 
Electrical excitability of beta-cells is strictly regulated by specific ion channels lo-
cated in the plasma membrane. The interplay between glucose metabolism and 
ion channels in beta-cells leads to this unique characteristic oscillatory pattern of 
the membrane potential (Vm) (Drews et al., 2015). 
1.2.1 ATP-sensitive potassium channels (KATP channels) 
KATP channels are potassium channels regulated by the intracellular nucleotides 
ATP and ADP. They are hetero-octamers containing sulfonylurea receptors 
(SUR1, SUR2A and B) and inwardly rectifying potassium channels (KIR) (KIR6.1 
or KIR6.2) (Aguilar-Bryan et al., 1998; Babenko et al., 1998; Bryan et al., 2007; 
Clement et al., 1997; Inagaki et al., 1995). KATP channels of beta-cells are con-
taining four KIR6.2 pore-forming subunits and four regulatory SUR1 subunits 
(Aguilar-Bryan, 1999; Clement et al., 1997; Inagaki et al., 1997; Shyng and Nich-
ols, 1997). The SUR1 subunit contains three transmembrane helices and two 
intracellular nucleotide-binding domains (Aguilar-Bryan et al., 1995). Interactions 
of the SUR1 subunit and MgADP lead to an increased open probability of the 
channel. The inhibitory effect of ATP is mediated through interactions with the 
pore-forming KIR6.2 subunits (Tanabe et al., 1999, 2000; Tucker et al., 1997). 
Drugs with an effect on KATP channel activity are often used to treat severe dis-
eases like e.g. T2DM (Cook, 1995; Füchtenbusch et al., 2000) or CHI (Lindley 
and Dunne, 2005). Important antagonists are sulfonylureas and glinides, which 
were often used to improve insulin secretion in T2DM. The blockage of KATP chan-
nels leads to a glucose-independent depolarisation of Vm. Channel agonists like 
e.g. diazoxide hyperpolarise beta-cell Vm and are important for the treatment of 
insulinoma (Gill et al., 1997) or diazoxide-sensitive CHI (Lindley and Dunne, 
2005). 
1.2.2 Voltage-dependent Ca2+ channels (Cav channels)  
Voltage-dependent Ca2+ channels (Cav) play an important role in glucose-in-
duced insulin secretion by triggering the exocytosis of insulin containing vesicles. 
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Cav channels consist of a pore-forming α1 subunit with a voltage sensor, a selec-
tivity filter for Ca2+ ions and so called activation and inactivation gates (Catterall, 
2000; Yang and Berggren, 2006). The additional subunits ß, γ, and α2/δ are re-
sponsible for the regulation of activation and inactivation of the channel.  
There are various types of Cav channels in beta-cells and the composition is spe-
cies dependent. But for insulin secretion the L-type Ca2+ channel is considered 
to be the most important one. In rodent beta-cells almost the complete Ca2+ cur-
rent is blocked by a specific L-type Ca2+ channel blocker (Gilon et al., 1997; Plant, 
1988). In addition, also insulin secretion is nearly completely diminished by the 
blockage of L-type Ca2+ channels in rodent, as well as in human beta-cells (Braun 
et al., 2008; Satin et al., 1995). 
As soon as the threshold for the activation of Cav channels is reached an influx 
of Ca2+ ions leads to an increase of [Ca2+]c which directly triggers the exocytosis 
of insulin. Bursts of action potentials lead to an influx of Ca2+ ions with its repeti-
tious pattern (oscillations) in the presence of a stimulatory glucose concentration 
(Bergsten et al., 1994; Gilon et al., 1993; Santos et al., 1991). 
1.2.3 Ca2+-activated K+ (KCa) channels and voltage-dependent K+ (Kv) 
channels 
KATP and Cav channels are important for the initiation of electrical activity and 
insulin secretion. The main function of voltage-dependent K+ (Kv) channels is the 
repolarization of action potentials (APs), whereas Ca2+-activated K+ (KCa) chan-
nels are involved in the regulation of Vm oscillations (Braun et al., 2008; Drews, 
2009; MacDonald et al., 2002). That means, without the repolarizing properties 
of these channels, it would be impossible for beta-cells to oscillate. Kv channels 
consist of alpha subunits which form the conductance pore. Sequence homology 
studies of the alpha subunits revealed the existence of 12 different classes of Kv 
channels (Gutman et al., 2005). Five subfamilies (Kv1, 2, 3, 6 and 9) are already 
confirmed in primary beta-cells (Göpel et al., 2000; Jacobson and Philipson, 
2007; MacDonald and Wheeler, 2003; Philipson et al., 1991; Roe et al., 1996; 
Yan et al., 2004). It could be shown that Kv currents consist of one 4-amino-
pyridine-insensitive current without inactivation which can be blocked by TEA+ 
and one inactivating current which can be blocked by 4-aminopyridine (Düfer et 
al., 2004; MacDonald et al., 2001; Smith et al., 1989; Su et al., 2001). 
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There are three groups of KCa channels 1) large-conductance BK channels, 2) 
intermediate-conductance SK4 channels and 3) small-conductance KCa channels 
(SK1, SK2 and SK3) (Tamarina et al., 2003). In 1984 Cook and Hales found out 
how the closure of the KATP channels triggers the initiation of the APs (Ashcroft et 
al., 1984; Cook and Hales, 1984). However, the origin of the current which hy-
perpolarises Vm during the initiation of the interburst phase was still unknown. 
Göpel and colleagues where the first who described the so called slowly rising 
outward current (IKslow) (Göpel et al., 1999). They could also show that part of the 
IKslow is caused by KATP channels. A significant breakthrough could be shown by 
Düfer and co-workers. Studies with SK4-KO mice revealed for the first time that 
KCa channels of intermediate-conductance (SK4) are part of the IKslow current in 
pancreatic beta-cells. The IKslow current is responsible for the repolarization of the 
burst phase (see chapter 1.4). Pharmacological modulation of SK4 channels by 
TRAM-34 (1-[(2-Chlorophenyl)diphenylmethyl]-1H-pyrazole) led to action poten-
tial broadening and depolarized the plateau potential from which action potentials 
started. The broadening of action potentials leads to an elevated insulin secretion 
(Düfer et al., 2009).  
1.3 Glucose-induced insulin secretion 
Postprandial increase of blood glucose concentration leads to an increase of glu-
cose metabolism in pancreatic beta-cells which is a prerequisite of insulin secre-
tion. Glucose is the dominant insulin secretagogue (Henquin and Meissner, 
1981). Besides glucose, other monosaccharides like fructose and mannose and 
also various types of amino acids and fatty acids can influence insulin secretion 
(Henquin and Meissner, 1981). The incretins, a group of intestinal hormones like 
GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic pep-
tide) are additional stimuli in the presence of glucose (Ebert and Creutzfeldt, 
1987). 
1.3.1 Stimulus-secretion coupling (SSC) 
Blood glucose concentration tightly correlates with the metabolic activity in beta-
cells and the ATP/ADP ratio influence electrical activity which on the other hand 
controls insulin secretion (Ashcroft and Rorsman, 1989). This process is called 
stimulus-secretion coupling (SSC). 
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A postprandial increase of blood glucose concentration leads to an augmented 
entering of glucose into the beta-cells. In rodent beta-cells glucose enters via low-
Km (Michaelis constant) Glut-2 transporters (Johnson et al., 1990), in contrast 
Glut-1 and Glut-3 are the predominant glucose transporters in human beta-cells 
(De Vos et al., 1995; McCulloch et al., 2011). The glycolysis is the metabolic 
pathway that converts glucose into the intermediates pyruvate and NADH. The 
glucokinase (GCK) with its Km in the range of the blood glucose concentration (~ 
5 mM) is the first enzyme of the glycolysis. The GCK is the so called glucose 
sensor and hence the rate-determining enzyme for glucose metabolism (Lenzen 
and Panten, 1988). The adaptation of the necessary amount of insulin for the 
organism is therefore firmly regulated by the activity of the GCK. The glycolytic 
reduction equivalent NADH is shuttled into the mitochondria by the malate-aspar-
tate and the glycerol phosphate shuttle systems. The inhibition of these shuttle 
systems completely suppresses glucose-induced insulin secretion demonstrating 
that only ATP resulting from the glycolytic reduction equivalents is able to influ-
ence KATP channels (Eto et al., 1999). The mitochondria are an essential link in 
the SSC of beta-cells. Within the mitochondria NADH is directly used by respira-
tory chains to pump H+ into the intra-membrane space of the mitochondria. This 
process leads to an electronegative environment within the mitochondria, a pre-
requisite for a proper function of F1/F0-ATPase. Pyruvate instead, is used by the 
citric acid cycle and non-specialized respiratory chains to produce for the energy 
demands for cell function, e.g. insulin synthesis or Ca2+ sequestration. By con-
trast, the energy produced by glycolytic NADH via specific respiratory chains is 
linked to specific mitochondrial creatine kinases to produce a high energy cyto-
solic creatine phosphate (CrP) (Gerbitz et al., 1996). The CrP is shuttled via spe-
cialised electron transport chains to the KATP channels located in the membrane, 
where another membrane-associated creatine kinase transfers the phosphate to 
ADP. The produced ATP leads to the closure of KATP channels with a subsequent 
depolarisation of Vm (Dzeja and Terzic, 2003; Krippeit-Drews et al., 2003; Ta-
rasov, 2006). The increase of the ATP/ADP ratio leads to a decrease of the open 
probability of KATP channels (Ashcroft et al., 1984; Misler et al., 1986), which leads 
to a depolarisation of the beta-cells via a yet unknown depolarising current (Hen-
quin, 1978; Rorsman and Trube, 1985; Sehlin and Taljedal, 1975). When the de-
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polarisation of the beta-cell exceeds the threshold for the opening of Cav chan-
nels, these channels open and Ca2+ ions enter the cell which leads to an increase 
of the intracellular Ca2+ concentration [Ca2+]c. The influx of Ca2+ ions are the direct 
trigger of insulin secretion via exocytosis of insulin containing vesicles. In rodent 
beta-cells APs are generated by L-Type Ca2+ channels, whereas e.g. in human 
beta-cells, a combined interaction between specific Na+ and Ca2+ channels is ob-
served (Braun et al., 2008). 
The whole process from glucose influx until insulin secretion is called SSC. A 
long-lasting impairment of SSC leads to T2DM. 
1.4 Membrane potential oscillations of beta-cells 
A remarkable and unique feature of pancreatic beta-cells is the capability to gen-
erate membrane potential (Vm) oscillations in response to stimulatory glucose 
concentrations. This phenomenon leads to a pulsatile insulin secretion (Gilon et 
al., 1993). It is still a matter of debate whether the oscillations of insulin are im-
portant for insulin sensitivity by avoiding down-regulation of insulin receptors 
(Hellman et al., 2007). It is also unclear how approximately one million islets in 
the pancreas are able to achieve synchronized oscillatory insulin secretion. At 
subthreshold glucose concentrations the beta-cell Vm is silent due to its hyperpo-
larization to a resting potential of about ~70 mV (Ashcroft and Rorsman, 1990). 
An increasing glucose concentration leads to the generation of electrical activity 
(see chapter 1.3) arranged in AP bursts and electrical inactive interbursts (Dean 
and Matthews, 1970a, 1970b). The oscillatory pattern of electrical activity in beta-
cells is also called slow waves. The synchronization of oscillations within an islet 
of Langerhans is due to a tight coupling of the cells via gap junctions (Benninger 
et al., 2008; Kuznetsov et al., 2005; Valdeolmillos et al., 1996). The burst and 
interburst length of an actively firing islet is glucose concentration dependent, i.e. 
with an increasing glucose concentration bursts are getting longer and interbursts 
shorter. The half maximal effective concentration (EC50) for glucose in mouse 
islets is reached at ~11 mM (Henquin, 2009) whereas continuous spike activity 
takes place at ~20 mM. The fraction of plateau phase (FOPP) which shows the 
calculated percentage of burst time can be used for the quantification of the Vm 
oscillations. 
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1.4.1 Positive and negative feedback mechanisms are essential for 





Fig 1: Burst versus interburst phase. (Left) Burst phase. Metabolism of glucose by 
glycolysis leads to the production of the intermediates NADH and pyruvate. Both inter-
mediates are taken up by the mitochondria. NADH is used by respiratory chains to pump 
H+ into the intra-membrane space of the mitochondria. This process leads to an electro-
negative environment within the mitochondria, a prerequisite for a proper function of 
F1/F0-ATPase. The metabolism of pyruvate and the reduction equivalents generated in 
the citric acid cycle are used to produce the bulk concentration of ATP to deliver energy 
for cell function. By contrast, the energy produced by NADH via specific respiratory 
chains is linked to specific mitochondrial creatine kinases to produce a high energy cy-
tosolic creatine phosphate (CrP). The CrP is shuttled via specialised electron transport 
chains to the KATP channels located in the membrane, where another creatine kinase 
transfers the phosphate to ADP. The produced ATP leads to the closure of KATP channels 
with a subsequent depolarisation of Vm. This activates voltage sensitive L-type Ca2+ 
channels and increasing [Ca2+]c triggers the exocytosis of insulin. (Right) Interburst 
phase. Electronegativity of the mitochondria enables a strong influx of the positive 
charged Ca2+ ions into the mitochondria. This initiates depolarisation of ΔΨ which leads 
to a reduction of F1/F0-ATPase activity and consequently to a decrease of cytosolic CrP 
and ATP production in the close vicinity of the KATP channels. Simultaneously an addi-
tional repolarising current through KCa channels is activated. The repolarising current 
produced by KATP channels and KCa channels is also called IKslow. The following repolari-
sation inactivates voltage sensitive L-type Ca2+ channels. Repolarization diminishes in-
sulin secretion and leads to the initiation of an interburst phase. 
A special feature of pancreatic beta-cells is that a continuous stimulating glucose 
concentration generates oscillations of electrical activity, [Ca2+]c and insulin se-
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cretion (Drews et al., 2015). This mechanism would be impossible without a neg-
ative feedback process, which is able to transiently lower electrical activity, [Ca2+]c 
and insulin secretion which lead to the formation of an interburst phase (Drews 
et al., 2015). There are reports about a positive feedback mechanism through 
glucose-induced increase of [Ca2+]c with subsequent increase of the mitochon-
drial Ca2+ concentration ([Ca2+]m). This enhancement of ([Ca2+]m) then stimulates 
Ca2+-dependent dehydrogenases and leads to a further stimulation of ATP pro-
duction (Kennedy and Wollheim, 1998). This positive feedback mechanism would 
lead, in the presence of a stimulating glucose concentration, to a continuous pro-
duction of ATP and consequently to a permanent closure of KATP channels. Other 
models propose a negative feedback process induced by [Ca2+]c itself (Fig. 1) 
(Drews et al., 2015). This process can be structured into two phases, whereas 
Phase 1 explains the mechanisms responsible for the generation of bursts and 
Phase 2 the generation of interbursts (Drews 2015 et al.): (Phase 1) Stimulatory 
glucose concentration leads via glucose oxidation to the generation of reduction 
equivalents (NADH, FADH2). Respiratory chains use the reduction equivalents to 
pump H+ into the intra-membrane space of the mitochondria (see chapter 1.3). 
This process leads to a hyperpolarization of the mitochondrial membrane poten-
tial (ΔΨ). The generated H+ gradient is necessary for the production of ATP by 
F1/F0-ATPase. The ATP which is derived from NADH is utilised by a mitochondrial 
creatine kinase to produce cytosolic CrP. After the transportation to the mem-
brane via enzyme systems, another creatine kinase uses the energy rich phos-
phate to produce ATP. The increasing ATP/ADP ratio in the close vicinity of the 
KATP channels leads to a decreasing open probability of the channels, which leads 
to a depolarisation of Vm. This subsequently activates voltage sensitive L-type 
Ca2+ channels and this initiates Ca2+ influx. The increasing [Ca2+]c is the direct 
trigger for insulin secretion. (Phase 2) Glucose concentration is still in a stimula-
tory range with a continued insulin secretion. During burst phase the mitochon-
drial ΔΨ is hyperpolarized which leads to an electronegative environment in the 
interior of the mitochondria. Regarding the high [Ca2+]c, it comes to Ca2+ influx 
into the mitochondria with subsequent depolarisation of ΔΨ (Krippeit-Drews et 
al., 2000). Depolarisation diminishes ATP production via F1/F0-ATPase and the 
open probability of KATP channels increases. At the same time an additional re-
polarizing current through SK4 KCa channels is activated. The KATP channel and 
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KCa channel currents are also called IKslow current. IKslow hyperpolarize Vm and 
[Ca2+]c decreases. This leads to hyperpolarization of ΔΨ and to closure of KCa 
channels. Thereafter ATP production increase again and Phase 1 starts again. 
 
1.4.2 Objective 
The MEA technology is an innovative technique to study the electrical activity of 
whole intact islets of Langerhans. We could demonstrate the `proof-of-principle´ 
for a MEA based method to study non-invasively the physiology and pathophys-
iology of islets of Langerhans (Pfeiffer et al., 2011). This study further aims to 
develop an assay for beta-cell damage induced by oxidative stress under con-
trolled ex vivo conditions and to find appropriate protection mechanisms against 
it (Schönecker et al., 2014). Moreover, this study aims to develop for the first time 
conditions that allow electrophysiological long-term investigations of beta-cell 
function (Schönecker et al., 2014). The study demonstrates for the first time that 
MEA technology allows the analyses of electrical activity of islets isolated from 
human biopsies. The second part of this study focuses on the development of an 
MEA based recording device for semi-automatic medium-throughput recordings 
for islets from animal models or from human biopsies. 
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2 Results and discussion 
An unique feature of pancreatic beta-cells is that they exhibit in whole intact islets 
of Langerhans oscillatory electrical activity also known as slow waves in response 
to glucose (Drews et al., 2010). Pfeiffer and colleagues were the first who showed 
oscillatory electrical activity recorded from primary, intact islets of Langerhans on 
top of planar microelectrodes (Pfeiffer et al., 2011). This enables for the first time 
calculations of the glucose dependence of FOPP using the MEA technology. For 
the calculation of the FOPP, it is necessary to record clearly definable oscillations 
with burst and interburst phases. This fluctuating electrical activity of [Ca2+]c (San-
tos et al., 1991) and the resulting insulin secretion (Bergsten et al., 1994; Gilon 
et al., 1993) is an excellent marker for intact beta-cell function and metabolism 
(Drews et al., 2010). Previously, two other work groups reported detections of 
islet cell activity by extracellular electrodes, but showed only spontaneous single 
spike activity (Bornat et al., 2010; Palti et al., 1996). 
2.1 Microelectrode array as a new approach in beta-cell 
physiology, pathophysiology and pharmacology 
Figure 2A shows a microscopic view of a freshly isolated intact murine islet. Islets 
with an average diameter of ~150 µm were used for recordings on a typical glass 
MEA chip (Multi Channel Systems (MCS), Reutlingen, Germany) shown in Fig. 
2B. For acute recordings, single islets were transferred to a MEA bath chamber, 
by using a holding pipette and fixed to an electrode with gentle mechanic pres-
sure (Fig. 2C). Other exemplary recording techniques developed during my PhD 
thesis are shown in Fig. 2D and E (Schönecker et al., 2014). Figure 2F displays 
a typical MEA recording with burst activity from a single murine islet. 
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Fig.2: Islet recordings with the MEA technology. A Microscopic view of a single mu-
rine islet of Langerhans. B Standard microelectrode array (MEA, Multi Channel Sys-
tems). C Islet of Langerhans placed on top of a MEA electrode during an acute meas-
urement. D Microscopic view of islets cultivated on the electrode field of a MEA for long-
term recordings. E View of a BetaScreen electrode covered with an intact murine islet 
positioned via negative pressure through the positioning holes. F Typical field potential 
recording of a murine islet with characteristic oscillatory activity in 10 mM glucose. 
The first important issue was to investigate whether MEA-based recordings are 
able to detect reliably glucose-dependent electrical activity of intact islets of Lang-
erhans. Therefore, extracellular recordings were compared to intracellular record-
ings obtained by classical techniques. Figure 3A shows a trace recorded with 
intracellular electrodes (taken from Drews et al., 2015), whereas Fig. 3B displays 
an extracellular recording via the MEA technique. Importantly, the appearances 
of action potential voltage deflections differ from each other. Extracellular rec-
orded signals show smaller positive and bigger negative amplitudes, whereas 
intracellular recorded signals show only positive voltage deflections. The reason 
for the different orientation of the signals is that the changes of Vm are measured 
by intracellular electrodes and the field potentials by extracellular electrodes. The 
shape of the extracellular potentials equal qualitatively the second time derivative 
of the intracellular Vm recordings which explains the bigger falling edge ampli-
tudes of the signals recorded with the MEAs. There are also differences in burst 
length between intra- and extracellular recordings (note different time scale in 
Fig.3). This is may be due to differences between individual islets. Another ex-
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planation could be the generation of leakage currents induced by invasive intra-
cellular electrodes, which may influence the burst length. Quantitative analysis of 
the signals, i.e. the calculation of the FOPP revealed a similarity of the glucose-
dependent patterns of electrical activity (see chapter 2.1.1) regardless of the re-
cording technique (Pfeiffer et al., 2011).  
 
Fig.3: Comparison of intra- and extracellular recordings. A Exemplary data of intra-
cellularly recorded membrane potential changes. Upward voltage deflections are Ca2+ 
action potentials defining the so-called plateau phase (figure taken from Drews et al., 
2015). B Field potential recording on a MEA electrode. The recording is qualitatively 
comparable to intracellular measurements. A and B in 10 mM glucose.  
2.1.1 Glucose-induced electrical activity of beta-cells 
Increasing extracellular glucose concentration leads, according to the consensus 
model of the stimulus-secretion coupling (Ashcroft and Rorsman, 1989), to Ca2+ 
APs with voltage deflection bursts which are detectable with MEA electrodes 
(Pfeiffer et al., 2011). The characteristic pattern of electrical activity can be di-
vided in two phases. The first phase is characterised by a very long burst followed 
by an extended silent period. Thereafter during the second phase, the typical 
oscillations of Vm take place (Drews et al., 2015). For the analyses of the fluctu-
ating electrical activity it is necessary to quantify the signals. The calculation of 
the FOPP is shown in Fig. 4C, whereas Figure 4A shows two representative MEA 
recordings from islets in 10 (lower trace) and 15 mM glucose (upper trace). Note 
the burst rate and hence the FOPP is higher in 15 mM compared to 10 mM glu-
cose. Glucose concentration response curve plotted as FOPP [%] is shown in 
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Fig. 4B, measured with MEA electrodes. The provided values range from 0% 
without activity for 3 mM glucose (n=10) to 100% which represents continuous 
spiking in 30 mM glucose (n=5). FOPP values increased with 6, 8, 10 and 15 mM 
glucose to 22 ± 3% (n=5), 36 ± 4% (n=5), 38 ± 3% (n=8), and 56 ± 4% (n=11), 
respectively. The half-maximal activity (50% FOPP) revealed 12 ± 1 mM, which 
is in agreement with data recorded with intracellular microelectrodes (11 mM) 
(Henquin, 2009) and clearly shows that extracellular MEA recordings from whole 
intact islets exhibit the same glucose dependence as recorded with intracellular 
electrodes. Interestingly, there is no electrical activity observable from alpha-
cells. This is due to the fact that alpha-cells display within intact islets the opposite 
glucose dependence as beta-cells, i.e. inhibition at high and activation at low glu-
cose (Rorsman et al., 1989). During the application of 3 mM glucose the electrical 
baseline appears (electrical noise) which is a random fluctuation in all electronic 
circuits. If alpha-cell activity would contribute to the baseline, it should be silenced 
shortly before the beta-cell activity appears after increased glucose concentra-
tion, but no changes were detected. In contrast to this Raoux and colleagues 
recorded electrical activity from dissociated alpha- and beta-cells revealed from 
mouse islets on the same MEAs but on different electrodes (Raoux et al., 2012). 
This can only be achieved when islets, prior to the cultivation, are dissociated to 
cell cluster or single cells via trypsin. Pfeiffer and Schönecker and colleagues 
showed that MEA recordings with whole intact islets display only beta-cell activity 
(Pfeiffer et al., 2011; Schönecker et al., 2014, 2015). In addition, the appearance 
of oscillations occur rarely in clustered beta-cells and never in dissociated single 
beta-cells which underlines the importance to record from whole intact islets. 
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Fig.4: Glucose-induced electrical activity and calculation of the fraction of plateau 
phase (FOPP). A Two MEA recordings from islets in 10 and 15 mM glucose. Electrical 
activity is higher in 15 than in 10 mM glucose. B Glucose concentration response curve 
plotted as FOPP [%] against glucose concentration [mM] (taken from Pfeiffer et al., 
2011). In 3 mM glucose no activity was detected while 30 mM led to continuous activity. 
C Graphic representation of the fraction of plateau phase (FOPP) quantifying beta-cell 
activity. 
2.1.2 Effects of ion channel modulators and simultaneous recordings of 
electrical activity and [Ca2+]c 
To further validate and proof the reproducibility of the signals, several ion channel 
modulators were tested on murine islets. The modulation of KATP channels with 
diazoxide (100 µM) a potent potassium channel activator resulted in a silencing 
of the oscillatory pattern (Fig. 5A). The activation of KATP channels via diazoxide 
leads to an increase of the hyperpolarising K+ outward current and hence to the 
closure of voltage sensitive L-type Ca2+ channels (Dunne et al., 1987; Henquin 
and Meissner, 1982; Trube et al., 1986). Thus diazoxide is often used to counter 
hypoglycaemia in diseases such as insulinoma or CHI (Gill et al., 1997). The os-
cillatory pattern can reappear after the addition of the KATP channel blocker tol-
butamide (150 µM) a sulfonylurea derivative (Fig. 5A). Sulfonylureas were an im-
portant class of antidiabetic drugs used to treat T2DM and act by increasing in-
sulin secretion via the closure of KATP channels (Gillis et al., 1989). Figure 5B 
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shows the blockage of oscillations by nifedipine which is a dihydropyridine L-type 
Ca2+ channel blocker (Vater et al., 1972). The blockage with nifedipine clearly 
displays the predominant role of L-type Ca2+ channels for the generation of APs 
in murine islets. Figure 5C compares simultaneous electrical recordings on a 
MEA with [Ca2+]c recordings via Ca2+ imaging. For this experiment the MEA was 
placed on an inverted microscope. The islet was incubated with the Ca2+ chelator 
fura-2 and then placed with mechanic pressure on top of a MEA electrode. Sub-
sequent excitation with 360 and 380 nm wavelength through the glass MEA re-
vealed changes of [Ca2+]c and at the same time glucose-induced electrical activity 
was measured by MEA electrodes. Importantly, each burst of APs was accom-
panied by a peak of [Ca2+]c (Fig. 5C). This findings were already shown by other 
groups who could show that [Ca2+]c (Santos et al., 1991) and insulin secretion 
(Bergsten et al., 1994; Gilon et al., 1993) are tightly coupled to the fraction of time 
beta-cells are bursting, underlining that the FOPP is an excellent marker for in-
sulin release. 
 
Fig.5: Ion channel modulation and simultaneous recordings of electrical activity 
and [Ca2+]c. A Recording of electrical activity in 15 mM glucose. Application of the KATP 
channel opener diazoxide (100 µM) results in a silencing of the oscillatory pattern. Addi-
tional application of the KATP channel blocker tolbutamide (150 µM), on the other hand, 
restored the electrical activity (FOPP in % in G15 = 61, G15+diazoxide = 0 and G15+di-
azoxide+tolbutamide = 100. One representative of 11 MEA recordings. B Application of 
the L-type Ca2+ channel blocker nifedipine (n=4) silenced oscillations recorded in 10 mM 
glucose (FOPP in % in G10 = 42, G10+nifedipine = 0 and after washout = 45). C Two 
examples of simultaneous recordings of electrical activity and [Ca2+]c. The upper traces 
(black) show glucose-induced electrical activity, and the lower traces (red) are recordings 
of [Ca2+]c. Importantly, each burst of electrical activity is accompanied by a peak of 
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[Ca2+]c. Glucose concentration was 10 mM (FOPP in % upper black trace = 40; FOPP in 
% lower black trace 38). (Fig.3 C in cooperation with Prof. Dr. Martina Düfer). 
2.2 A superoxide dismutase (SOD) mimetic protects beta-
cells against acute oxidative stress 
An important milestone of my thesis was the development of an in vitro environ-
ment capable to induce oxidative stress on MEAs. It is well accepted that oxida-
tive stress, as a result of excessive fuel intake (modern lifestyle) within pancreatic 
beta-cells is a key event in the development and progression of T2DM (Poitout 
and Robertson, 2008). That oxidative stress impairs beta-cell function and inhibits 
glucose-stimulated insulin secretion is already known (Akesson and Lundquist, 
1999; Krippeit-Drews et al., 1999). Since, the equipment with antioxidant en-
zymes (e.g. catalase (Cat), glutathione peroxidase (Gpx) and superoxide dis-
mutase (SOD)) seems to be low in beta-cells (Lenzen et al., 1996), it would be of 
great importance to find strategies to prevent oxidative stress. The development 
of an in vitro model capable to induce a defined stress level on top of MEA elec-
trodes would help to understand the effect of stress-induced damage to beta-cells 
and to find strategies against it. An important question was whether the islet re-
cordings with the MEA technology are sensitive enough to allow the detection of 
small changes in electrical activity induced by stress. It would be even more im-
portant to be able to detect protective effects against stress induction with the 
help of MEA recordings. In the present study I investigated hydrogen peroxide 
(H2O2) induced changes in electrical activity of mouse beta-cells recorded on 
MEAs. H2O2 is an oxygen species which generates oxidative stress within pan-
creatic beta-cells (Poitout and Robertson, 2008). The effect of different H2O2 con-
centrations on the electrical activity of islets was examined. Figure 6A shows one 
typical recording of the application of 300 µM H2O2 in the presence of 10 mM 
glucose. The decreasing effect of H2O2 on electrical activity is clearly detectable 
with the MEA technology. The concentration-response curve shows the decreas-
ing effect of H2O2 on the FOPP (Fig. 6B), (n=3-14. **P ≤ 0.01 *** P ≤ 0.001 com-
pared to control without H2O2). The results illustrate clearly that H2O2 markedly 
contribute to changes in electrical activity. These findings are in line with another 
study who showed that H2O2 is one of the reactive oxygen species which strongly 
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contributes to an increasing KATP current (Krippeit-Drews et al., 1994). Further-
more, alterations in electrical activity or KATP channel current in the presence of 
H2O2, nitric oxide (NO) or other reactive oxygen species (ROS) and reactive ni-
trogen species (RNS) donors have been described (Drews et al., 2000; Krippeit-
Drews et al., 1994, 1995, 1999; Nakazaki et al., 1995; Tsuura et al., 1994). The 
next step was to investigate whether the membrane-permeable SOD mimetic, 
tempol (Fleenor et al., 2012), is able to protect beta-cells against H2O2-induced 
effects on electrical activity. To avoid a direct extracellular contact of tempol and 
H2O2 the islets were pre-incubated with tempol (1 mM) prior to the application of 
300 µM H2O2. As shown in Fig. 6C and D a 30 min pre-incubation of 1 mM tempol 
(n=14) protected the islets against the application of 300 µM H2O2. In addition 
tempol has also a protective effect on insulin secretion shown in Fig. 6E (n=6). 
There are differences in the effectivity of the H2O2 effect on insulin secretion and 
electrical activity which is most likely due to slight differences in the experimental 
procedure (perfusion for the measurement of electrical activity vs. 1 hour steady-
state incubation for insulin secretion). The results clearly show that tempol has a 
protective effect on insulin secretion by avoiding the damaging effects of H2O2 on 
SSC. This is in agreement with previous observations that up-regulation of anti-
oxidant enzymes protects beta-cells against oxidative stress (Gier et al., 2009). 
Moreover, the data demonstrate that SOD could be an important key player in 
the antioxidant defence of beta-cells which seems to be even more important 
than Gpx and Cat. This can be explained by the fact that the application of SOD 
alone is already effective and protects against oxidative stress. Interestingly, the 
main substrate of SOD is not H2O2, but rather the superoxide anion radical (O2-) 
which can react with critical cellular targets e.g. with NO to toxic peroxynitrite. The 
question that arise is, how does SOD protect against the application of H2O2. It is 
presumed that the tempol-dependent protection is due to the degradation of 
H2O2–induced ROS production including O2-. It is known that H2O2 leads to a 
partial depolarization of the mitochondria (Nakazaki et al., 1995) and a decrease 
of ΔΨ is assumed to increase ROS production (Krippeit-Drews et al., 1999). 
Moreover, ROS in general, including H2O2 is known to induce mitochondrial ROS 
release (Zorov et al., 2006). This mechanism is well known in cardiomyocytes 
and involves the mitochondrial permeability transition pore/or the anion channel 
of the inner mitochondrial membrane. In both cases the generation of O2- in the 
Results and discussion    34 
mitochondria would increase and intensify ROS generation and action. We hy-
pothesize that this vicious circle is stopped by the SOD mimetic (Schönecker et 
al., 2014). The results show the successful establishment of an oxidative stress 
model on top of MEAs and demonstrate the protective effect of the SOD mimetic 
tempol on electrical activity of beta-cells and insulin secretion. 
 
 
Fig.6: Effect of H2O2 on electrical activity in mouse islets and the protective effect 
of tempol against H2O2-induced reduction of electrical activity. A Typical extracel-
lular MEA recording of glucose-induced oscillations before and during application of 0.3 
mM H2O2 (n=14). B Dose-response curve showing the decrease of the FOPP in the 
presence of H2O2 (n=3-14. **P ≤ 0.01 *** P ≤ 0.001 compared to control without H2O2). 
C Original recordings in 10 mM glucose (upper trace), 10 mM glucose and 0.3 mM H2O2 
(middle trace) as well as in 10 mM glucose and 0.3 mM H2O2 after preincubation in 1 
mM tempol (lower trace). The protective effects of tempol on FOPP (D) and insulin se-
cretion (E) (Fig.6 E performed from the workgroup of Prof. Dr. Gisela Drews, University 
of Tübingen). 
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2.3 Establishment of a long-term culture of intact murine 
islets on MEAs  
The development and progression of the pathogenesis of T2DM is a long-lasting 
process. And as mentioned above, all current electrophysiological techniques 
used in beta-cell research are invasive which makes in vitro long-term investiga-
tions of islets impossible. Therefore, it would be of great advantage for islet re-
search to overcome these limitations and to find a way to develop culture condi-
tions for long-term investigations of intact islets in order to come as close as pos-
sible to the in vivo situation. Therefore, the next aim was to develop a system 
allowing a long-term culture of intact islets on MEAs. The first challenge was to 
find an appropriate substrate for the islets so that they can attach on the MEA 
surface. Matrigel (Corning Life Science) is a gelatinous protein mixture produced 
by Engelbreth-Holm-Swarm mouse sarcoma cells and is similar to the extracel-
lular matrix found in most tissues (Hughes et al., 2010). Matrigel allows the coat-
ing of substrates, such as the MEA surface, having a thin layer with a thickness 
in the range of a few micrometer (Hughes et al., 2010). This thin Matrigel layer 
turned out to be a very good substrate for the cultivation of islets on top of MEAs. 
Figure 7 (upper left) shows a microscopic view of an electrode field of a MEA with 
cultivated islets grown on top. This example shows islets already cultured for 12 
days on the MEA surface. Importantly, they still display glucose-dependent elec-
trical activity comparable to acute recordings. Typical oscillations simultaneously 
recorded from seven islets (red circles) are presented aside (black traces), show-
ing the increase in electrical activity with increasing glucose concentrations (Fig. 
7).  
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Fig.7: Parallel recordings of beta-cell activity from different islets after long-term 
cultivation (12 days in vitro) on MEAs. Upper left: Microscopic view of islets cultivated 
on the electrode field of a MEA. Typical oscillations from seven islets (red circles) are 
presented aside, showing the increase in electrical activity with increasing glucose con-
centrations. Note: the activity was recorded from islets already cultured for 12 days on 
top of the MEA surface. The FOPP in 10 mM glucose amounted to 22 ± 3% (n=7) and 
for 15 mM glucose 40 ± 4% (n=7). 
Next it was highly important to elucidate whether the electrical activity of islets is 
preserved in culture. Therefore, I examined the glucose-induced electrical re-
sponsiveness of the islets over several weeks and compared the data with the 
results of the previously obtained acute recordings. Two exemplary traces from 
islets cultured 6 and 34 days on a MEA are shown in Fig.8A. During the applica-
tion of 3 mM glucose no activity was detectable, whereas an increase to 10 and 
15 mM glucose induced electrical activity even after 34 days in culture. In a series 
of measurements electrical activity of cultured islets was recorded in the presence 
of 10 and 15 mM glucose for different days of culture (Fig. 8B). Differences of 
electrical activity recorded in 10 mM compared to 15 mM glucose was clearly 
distinguishable, showing the preservation of electrical activity up to 34 days in 
culture. Quantification of the FOPP in the presence of 10 and 15 mM glucose for 
different days of culture. *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001. Statistical differences 
between the FOPP at 10 and 15 mM glucose at each culture day. The n-values 
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within the columns indicate the number of islets. 5 different preparations are in-
cluded in this series of experiments. To examine whether there are culture time-
dependent alterations in electrical activity, the FOPP was pooled for experiments 
recorded in the first week (day 6 and 7) and compared to recordings obtained in 
the last week (day 33 and 34). The FOPP calculated for the first week amounted 
to 32 ± 3% (n=8) for 10 mM glucose and 70 ± 6% (n=8) for 15 mM glucose. The 
calculations for the last week revealed 36 ± 2% (n=7) for 10 mM glucose and 72 
± 5% (n=7) at 15 mM glucose. This data clearly show that the FOPP did not 
change over time in culture and is even after 34 days comparable to acute re-
cordings carried out with freshly isolated islets (Fig. 8B right). The establishment 
of a long-term culture of intact murine islets on MEAs is the first electrophysiolog-
ical approach allowing long-term investigations of whole intact islets (Schönecker 
et al., 2014). Raoux and co-workers cultivated clonal INS-1E cells on MEAs and 
reported a reduced AP frequency after 3 days at elevated glucose concentration 
(Raoux et al., 2012). It can be speculated, that the reduction of the spike rate of 
INS-1E cells over the cultivation time is due to differences in the cellular environ-
ment in comparison to intact islets. To investigate changes in islet cells in a T2DM 
promoting environment it is a great advantage to record from structurally intact 
primary islets to come as close as possible to the in vivo situation. Furthermore, 
it is possible to study the oscillatory activity of the same islet on different days, 
which enables to monitor e.g. long-term effects of anti-diabetic drugs. Another 
beneficial effect is the increase of throughput. The rate of successful experiments 
could be enhanced by a factor of approximately 8 compared to a single islet re-
cording with the acute method. Theoretically 60 islets could be placed and rec-
orded on a standard MEA simultaneously. To obtain this amount of recordings 
per MEA, further advancements are necessary. The most important step would 
be to develop a surface patterning which allows a targeted placement of the islets 
on individual electrodes. First prototypes are already developed and will be tested 
at the NMI (The Natural and Medical Sciences Institute at the University of Tü-
bingen). 
This new development will revolutionise electrophysiological in vitro experiments 
and paves the way to perform long-term recordings of electrical activity with low 
concentrations of redox-active compounds or diabetes-inducing agents, and also 
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to study progressive changes evoked by gluco-, lipo- or glucolipotoxicity. Moreo-
ver, the method allows developing co-culture experiments with other cell types or 
tissues to investigate whether there are influences on electrical activity. 
 
Fig.8: Electrical activity of islets is preserved in culture. A Two representative re-
cordings from islets cultured already 6 and 34 for days on a MEA. Electrical activity was 
induced by the application of 10 and 15 mM glucose, whereas no activity was detectable 
with the sub-threshold concentration of 3 mM glucose. B (left) FOPPs for glucose con-
centrations of 10 and 15 mM are not significantly altered up to 34 days in culture and are 
comparable to (right) FOPPs recorded from freshly isolated islets. *P ≤ 0.05, ** P ≤ 0.01, 
*** P ≤ 0.001. Statistical differences between the FOPP at 10 and 15 mM glucose at 
each culture day. The n-values within the bars indicate the number of islets. 5 different 
preparations are included in this series of experiments.  
2.4 Human islets exhibit electrical activity on MEAs and on 
the new developed BetaScreen device 
Most of the fundamental knowledge about pancreatic beta-cells was achieved 
from research with animal models. This is due to limited access to human biop-
sies, and if available, the quality and the number of the islets are often very low. 
Nevertheless, in recent years successively more and more studies have been 
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made with human beta-cells. These studies demonstrated various important dif-
ferences between rodent and human beta-cells. This underlines the importance 
to further improve the current scientific knowledge about human islets. An im-
portant tool to improve these investigations could be the MEA technology. This 
study demonstrates for the first time that the MEA technique is suitable to record 
electrical activity from human islets (Schönecker et al., 2015).  
Human islets were obtained either from biopsies taken during pancreatic surgery 
or from organ donors isolated according to the Edmonton Protocol. To verify 
whether the MEA technology is able to record electrical activity from human islets, 
different recording methods were tested. Figure 9 shows microscopic views of 
different recording techniques tested with human islets. The left photo (Fig. 9A) 
displays the mechanical placement of an islet via a holding pipette during an 
acute recording. A human organotypic pancreatic slice on top of a MEA is shown 
in Fig. 9B fixed by a platinum grid and a human islet culture on the electrode field 
of a MEA can be seen in Fig. 9C. An exemplary recording of electrical activity of 
a human islet received from an adult donor with the acute technique is shown in 
Fig. 9D. During the application of 1 mM glucose no activity could be recorded 
whereas electrical activity started after the application of 10 mM glucose. The 
additional application of the sulfonylurea tolbutamide (100 µM) increased the glu-
cose-induced activity clearly. In other recordings, spike activity could be inhibited 
by diazoxide (Schönecker et al., 2015). Interestingly, electrical activity could also 
be obtained from a pancreatic slice of a child with CHI. This demonstrates that 
MEA recordings with human pancreatic tissue is not depending on the age of the 
donor. Importantly, the recordings were obtained from different isolation proto-
cols. Either by an isolation protocol similar to the one which I used for the isolation 
of primary mouse islets, or from organ donors isolated according to the Edmonton 
Protocol (Shapiro et al., 2000). The Edmonton Protocol for islet cell transplanta-
tion was developed at the University of Alberta Hospital (Edmonton, Canada) to 
guarantee a quality standard for the isolation of human islets prior to the trans-
plantation into patients with type 1 diabetes. The recording which can be seen in 
Fig. 9D was obtained from an islet isolated according to the Edmonton Protocol. 
The success rate of the human islet recordings with the MEA-technology was 
higher with the Edmonton Protocol. We hypothesize that the isolation process 
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and therefore the quality of the human islets is a very critical point for successful 
recordings. 
 
Fig. 9: Human islet activity can be recorded with the MEA technology. A Micro-
scopic view of an islet placed by mechanical pressure with a holding pipette during an 
acute measurement. B Pancreas slice from a child with CHI on top of a MEA. C Culti-
vated human islets on MEA electrodes. D Electrical activity of a human islet of Langer-
hans obtained from an adult donor. The application of 10 mM glucose (FOPP in % = 35) 
evoked spike activity and additional application of tolbutamide further increased the 
spikes (FOPP in % = 85). 
As recent studies demonstrated that there are important differences between ro-
dent and human beta-cells (Rorsman and Braun, 2013). One important example 
is the effect of the voltage-dependent Na+ channel blocker tetrodotoxin. Figure 
10A shows a strong inhibition of TTX (300 nM) on the electrical activity of a hu-
man islet (n=11) (Schönecker et al., 2015). Interestingly, the effect of TTX did not 
completely diminish spike activity and the effect was reversible. Figure 10B 
shows a comparable recording on a murine islet. In contrast to human islets, TTX 
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did not influence electrical activity of mouse islets (n=3) (Schönecker et al., 2015). 
These findings are in line with the data reported by Braun et al. (Braun et al., 
2008), were he could show that the gating of voltage-dependent Na+ channels 
plays an important role for electrical activity in human islets. The application of 
300 nM TTX which is a selective and effective inhibitor of voltage-gated Na+ chan-
nels, reduced burst activity largely and reversibly as shown in Fig. 10A. Moreover, 
the results show clearly that TTX inhibits burst activity not completely and that 
there is activity remaining. Responsible for the remaining activity are most likely 
still active L-type Ca2+ channels. L-type Ca2+ channels and Na+ channels are im-
portant for the initiating of the APs. This can be confirmed through the inhibitory 
effects of the Ca2+ channel blocker isradipine together with TTX on insulin secre-
tion in human islets (Rorsman and Braun, 2013). The comparison to mouse islets 
(Fig. 10A and B) shows one of the important differences between mouse and 
men within the SSC of beta-cells. TTX exhibits a strong effect in human islets, 
whereas mouse islets remain unaffected. These findings are in line with Plant 
(Plant, 1988) who showed that Na+ channels of mouse beta-cells are not func-
tional at physiological membrane potentials. 
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Fig.10: Comparison of the tetrodotoxin (TTX) effect on electrical activity of human 
vs. mouse islets. A The application of 300 nM TTX almost completely diminished elec-
trical activity of a human islet (n=11) in the presence of 10 mM glucose and 100 µM 
tolbutamide (Spike activity in 10 mM glucose 1047 ± 314, glucose and TTX 199 ± 90 and 
after the washout of TTX 779 ± 301). B TTX is without effect on electrical activity of a 
murine islet in the presence of 10 mM glucose (n=3) (FOPP in % for 10 mM glucose = 
61 ± 9, FOPP in % in 10 mM glucose and 300 nM TTX = 60 ± 8 and after the washout of 
TTX = 63 ± 9). 
2.4.1 Transfer of human islets of Langerhans to the BetaScreen approach 
The BetaScreen (see chapter 3) is a very useful new electrophysiological medium 
throughput screening device for whole intact murine islets of Langerhans. As well 
as for mouse islets, an increase of throughput for the human islet recordings 
would be of great scientific interest. This study obtained for the first time simulta-
neous electrophysiological recordings of human islets by means of the  
BetaScreen device. The recordings with the BetaScreen device enabled to record 
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a high number of primary human islets in a short time. This was highly important 
since the quality of human islets decreases over the time. The declining quality 
of the human islets makes it very difficult to obtain an adequate amount of meas-
urements during the short timeframe which exists for the recordings. The increase 
of successful recordings paved the way to quantify pharmacological modulations 
of the electrophysiological recorded signals and revealed for the first time a glu-
cose concentration-response curve obtained from human islets on a MEA sys-
tem.  
For the quantification of the electrical activity from human islets recorded with the 
BetaScreen device, the number of single spike activity (spikes/5min) was used, 
due to the absence of oscillations. The validation studies with tolbutamide and 
diazoxide showed the existence of functional KATP channels. Fig. 11A shows the 
effects of diazoxide (100 µM, n=10) and tolbutamide (150 µM, n=10) on spike 
activity. Diazoxide reduced the mean spike activity from 833 ± 339 spikes/5min 
(10 mM glucose) to 8 ± 4 spikes/5min. The additional application of tolbutamide 
restored spike activity up to 876 ± 310 spikes/5min. The quantification of the TTX 
effect is shown in Fig. 11B. Spike activity was reduced from 1047 ± 314 to 199 ± 
90 spikes/5min after the application of 300 nM TTX (n=11). The washout led to 
an increase of spike activity to 779 ± 301 spikes/min (n=11). The glucose con-
centration-response curve of the spike activity is shown in Fig. 11C. Spike activity 
increased from 118 ± 35 (n=11), 142 ± 31 (n=11), 368 ± 58 (n=31), 710 ± 90 
(n=11) to 945 ± 156 spikes/5min with 1, 3, 5, 8 and 10 mM glucose, respectively. 
The Hill equation fitting revealed an EC50 value of 8.66 ± 3.02 mM glucose which 
is lower than in mouse islets. The glucose responsiveness in human islets rec-
orded with the MEA-technology is in line with other reports showing that the EC50 
value of human beta-cells (~ 6 mM) is smaller than in mouse beta-cells (~ 11 mM) 
(Rorsman and Braun, 2013). This differences explain the fact that the nonfasting 
plasma glucose concentration is lower in human (~5 mM) (Frayn 2010) than in 
mice (7-10 mM) (Li et al., 2009; Remedi et al., 2011). That the higher glucose 
sensitivity of human islets is due to intrinsic beta-cell properties, could be shown 
by Ricordi and co-workers who transplanted human islets into diabetic mice. The 
result was that the insulin secretion of the human beta-cells regulated plasma 
glucose at the normal nonfasting glucose concentration for humans rather than 
at the nonfasting glucose concentration for mice (Ricordi et al., 1991). Example 
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of an insulin secretion experiment is shown in Fig.11D. Glucose-induced insulin 
secretion was obtained from adult human islets. The islets secreted only a small 
percentage of the stored insulin which was less than 0.06% of 10 ± 1.6 µU/10 
islets (n=7) and glucose-induced insulin secretion did not become significant 
showing a low responsiveness of this preparation to glucose.  
As already mentioned above, the recordings with human islets revealed only sel-
dom electrical oscillations in comparison to mouse recordings. Therefore, I used 
the quantification of single spikes per five minutes for the analyses. A similar ob-
servation is shown by Rorsman and Braun (Rorsman and Braun, 2013), where 
58% of the recordings showed single spike activity and only 26% oscillatory ac-
tivity. The question arise of whether such a behaviour reflects the physiological 
behaviour of the human islets, or if this is only seen in in vitro experiments due to 
possible stress factors after the isolation process of the islets. It is a fact that more 
in vitro recordings from human islets are necessary to answer this kind of ques-
tions and the MEA technology with the capability of higher throughput recordings 
can help to generate answers. 
In conclusion, the MEA method emerges as a new important tool for the investi-
gation of rodent and human islets in vitro. The MEA technique will increase the 
success rate of the recordings which is important due to limited access of, e.g. 
human pancreatic tissue probes. The development of murine islet cultures on top 
of MEA electrodes for long-term recordings can also be transferred to human 
islets. And last but not least, human islet recordings with the medium-throughput 
BetaScreen device (see chapter 3) can be used for pharmaceutical drug screen-
ings and even to test human islets for metabolic integrity before transplantation. 
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Fig.11: Recordings of human islets with the BetaScreen device and insulin secre-
tion measurements A Effect of diazoxide and tolbutamide on spike activity of intact 
human islets. Diazoxide (100 µM, n=10) strongly reduced spike activity, whereas addi-
tional application of tolbutamide (150 µM, n=10) reversed this inhibition. B TTX reduced 
spike activity significantly (300 nM, n=11). The effect of TTX is reversible, which can be 
seen after the washout of the toxin (n=11). C Glucose concentration-response curve of 
spike activity. Spike activity increased with increasing glucose concentrations. The data 
are fitted with the Hill equation and revealed a half-maximal glucose concentration of 
8.66 ± 3.02 mM. D The insulin secretion experiment was performed from the workgroup 
of Prof. Dr. Susanne Ullrich from the Universitätsklinikum Tübingen and showed that the 
islets secreted only a small percentage of the stored insulin and glucose induced insulin 
secretion did not become significant indicating a low responsiveness of this preparation 
to glucose.  
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3 BetaScreen device 
The aim of the project was to develop a MEA-based parallelized recording system 
for the investigation of acute intact islets of Langerhans called BetaScreen. The 
BetaScreen project was a cooperation between the company MCS (Multi Chan-
nel Systems, Reutlingen, Germany) and the institution NMI (Natural and Medical 
Science Institute at the University of Tübingen, Reutingen, Germany) under sci-
entific consulting of Prof. Dr. G. Drews  and Prof. Dr. P. Krippeit-Drews (Depart-
ment of Pharmacology, Institute of Pharmacy, University of Tübingen, Germany). 
The development of the BetaScreen Device was funded by the BMBF-program 
KMU innovative: Biotechnolgie-BioChance, #0316162B. 
3.1 Development of a MEA based parallelized screening 
system for primary intact islets of Langerhans called 
BetaScreen 
Recordings of cultured islets (see chapter 2.3) is a very useful tool for long-term 
investigations of islets but not for acute drug application. This is due to the fact 
that the cultivation process, i.e. the attachment of the islets on the MEA surface, 
takes at least two days until the recordings can start. And the number of experi-
ments for acute islet recordings so far was restricted to one recording per exper-
iment which is too time consuming and cost-intensive due to high labor costs. 
Therefore, it was of great importance to find a way to enhance the throughput 
and the handling of the recordings to a convenient level to meet the need of both 
academic and industrial laboratories. The field of application for the BetaScreen 
device can comprise 1) clinical basic research in the field of experimental diabe-
tes research 2) quality check of islets used for transplantation and 3) pre-clinical 
drug development.  
3.2 First prototype of the BetaScreen recording device 
The first recording device used for the BetaScreen project was based on the 
USB-MEA32STIM4-System from MCS with integrated amplifier, filter amplifica-
tion and analog/digital board (Fig.12A). Moreover, the device was equipped with 
a perfusion heating and the possibility to apply suction (negative pressure) from 
below via a vacuum pump with pressure sensor and waste bottle (Fig.12C). For 
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the positioning of the islets via suction a new MEA development was necessary 
(Fig.12B). The first MEA prototype was equipped with five electrodes within a 
round recording chamber. In the middle of each electrode was a positioning hole  
 
Fig.12: The first prototype of the BetaScreen device. A USB-MEA32STIM4 head-
stage from MCS with integrated amplifier, filter amplification and analog/digital board. B 
Newly designed first MEA prototype with 5 electrodes within a round recording chamber 
(NMI). C Constant vacuum pump (CVP) with pressure sensor to record the target pres-
sure in relation to the current ambient pressure. 
arranged to enable the placement of islets via suction. Recordings with the new 
developed electrodes were not successful (n > 50). The initial presumption that 
the impedances of the electrodes are too high couldn’t be confirmed. Impedance 
measurements revealed values of ≤ 50 kunder a physiological relevant fre-
quency of 1 kHz) which is in the optimal range (n=95). However, the examination 
of the hole structure showed that the main reason for the failure to record electri-
cal activity was the fact that the contact of the islets to the electrodes was not 
tight enough. The reason for that were process-related differences in the struc-
ture of the holes which led to different heights of the hole rims on the MEA sur-
face. This could be further confirmed by measurements of the diameter of the 
positioning holes which showed big differences. The diameter varied from 9 µm 
up to 32 µm (n=9) (see Fig.13). 
 
BetaScreen device    48 
 
Fig.13: Technical drawing of the first MEA prototype for the BetaScreen device 
and microscopic photos of single electrodes with positioning holes. A Technical 
drawing of the MEA with channel map, round recording chamber, five recording elec-
trodes and reference electrode (see red arrows). B Microscopic photos of eight recording 
electrodes with positioning holes (see red arrow). The differences in size and shape with 
irregular hole rims are clearly visible. The measurement of the diameter of the electrodes 
revealed big variations. The diameter varied from 9 µm up to 32 µm (n=9). 
3.3 The usage of perforated MEAs for the placement and 
recordings of islets via suction 
As it turned out that the first approach with the positioning hole in the centre of 
the electrodes did not provide a proper contact of the islets to the electrodes, a 
new strategy was needed. The new strategy was based on the idea of the already 
existing perforated MEA (pMEA) technology developed from MCS. These MEAs 
were developed to record electrical activity from acute brain slices placed via 
suction. The electrodes are placed on top of a polyimide foil and the foil is fixed 
to a ceramic substrate to achieve mechanical stability. The area around the re-
cording electrodes is perforated which allows to either perfuse the biological 
probe from both sides or to apply negative pressure. For the first pilot studies I 
used modified pMEAs to test whether this approach can improve the contact of 
the islets to the electrodes. For the pilot study a polyimide foil with an exact de-
fined hole was glued on top of the surface of the pMEAs, so that only three elec-
trodes with positioning holes around were uncovered (see Fig.14). An additional 
improvement was the usage of titanium nitride electrodes which provide a better 
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signal to noise ratio due to lower impedances in comparison to the gold elec-
trodes used for the first prototype. 
 
Fig.14: Detailed view of a pMEA with glued polyimide foil used for pilot study re-
cordings. A Polyimide foil with defined hole at the lower left part of the foil. B pMEA with 
glued polyimide foil on top of the MEA surface. C Detailed view of the defined hole in the 
foil with recording electrodes and positioning holes in the center. 
The attempt with the pMEAs worked and I recorded for the first time electrical 
activity from an islet in 10 mM glucose placed via suction on top of a MEA (see 
Fig.15). This was the “proof of principle” that this approach is possible and that 
islets are placeable and recordable by means of positioning holes and negative 
pressure. This first result showed that this strategy is promising and was the kick-
off for a new pMEA-based development specifically designed for islet recordings. 
 
Fig.15: Proof of principle recording on top of a perforated MEA in 10 mM glucose. 
(Left) General view of oscillatory activity recorded from one islet on top of two electrodes 
(Right) Enlarged view of a trace with oscillations recorded with one of the electrodes on 
the left. 
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3.4 Development of new electrodes designed for the 
placement of islets via suction 
As with the previously used prototypes the electrodes are placed on top of a pol-
yimide foil. The electrode material is titanium nitride and negative pressure can 
be applied from the bottom side of the MEA. The electrodes are surrounded with 
positioning holes to ensure a proper positioning of the islets on top of the elec-
trodes (see Fig.16). In order to find out which electrode size is optimal for the 
placement of islets two different electrode sizes were used, electrodes with 30 
µm and with 50 µm in diameter (Fig.17). 
 
Fig.16: Draft of a new design of a 30 µm titanium nitride electrode. (Black) Record-
ing electrode with 30 µm diameter (round shape) and electrode tracks 12 µm broad. 
(Grey) Positioning holes with 15 µm diameter are located around the recording electrode. 
The quality measurements after the manufacturing process revealed impedances 
(at a frequency of 1 kHz values of ≤ 50 k) of the electrodes which are compara-
ble to the standard MEAs produced at the NMI and sold by MCS. The first MEAs 
used for the test recordings were equipped with five electrodes within a recording 
chamber. Negative pressure was applied with a vacuum pump and recording so-
lution was perfused with a peristaltic perfusion system with one inlet and one 
outlet pump. 
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Fig.17: Microscopic image of the new electrodes. A Three electrodes located in a 
recording chamber with electrode tracks coming from the right B Electrode with 50 µm 
in diameter and surrounding positioning holes C Electrode with 30 µm and surrounding 
positioning holes. 
One of the first recordings of electrical activity with the new electrodes is shown 
in figure 18. After pipetting the islets into the recording chamber they positioned 
themselves on top of the electrodes without further support. The application of 50 
mbar negative pressure during the pipetting turned out to be ideal for the posi-
tioning. To avoid damage of the islets negative pressure was reduced to 10 mbar 
after the positioning process. Moreover, not only the placement could be facili-
tated, but even the signal to noise level is significantly improved in comparison to 
the acute recordings. The improved signal to noise ratio could be achieved due 
to a better contact between islets and electrodes. A further advantage is that the 
value of the negative pressure can be adjusted during an ongoing experiment to 
a currently needed value.  
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Fig.18: Proof of principle recording with a new designed BetaScreen electrode. 
(Left) Microscopic photo of an islet placed with 50 mbar negative pressure on top of a 
BetaScreen electrode which is surrounded with positioning holes. (Right) Trace with 
electrical activity of the islet which is shown on the left side in 10 and 12 mM glucose. 
Note that the negative pressure was reduced to 10 mbar after the placement of the islet. 
The signal to noise ratio is improved in comparison to acute recordings. 
3.5 Physiological and pharmacological validation of the 
prototype system  
An important question was whether the properties of the electrical activity are 
comparable to literature as well as to the acute recordings obtained with the clas-
sical MEA chips. To be sure that the positioning with negative pressure did not 
influence the behaviour of the recorded electrical signals, validation studies were 
necessary. The glucose concentration response curve plotted as FOPP (see 
Fig19A) recorded with the BetaScreen prototype revealed a half-maximal activity 
of 12,26 ± 2 mM, which is comparable to the results obtained with acute MEA 
recordings (12 mM) (Pfeiffer et al., 2011). Moreover the data are in agreement 
with data recorded with intracellular microelectrodes (11 mM) (Henquin, 2009). 
The values range from 0% without activity for 3 mM glucose (n=16) and the val-
ues increased with 6, 8, 10, 12 and 15 mM to 1 ± 1% (n=4), 27 ± 2% (n=12), 36 
± 4% (n=11), 46 ± 5% (n=8) and 65 ± 13% (n=6), respectively. To further validate 
the reproducibility of the new prototype the KATP channel modulators tolbutamide 
and diazoxide were tested (see Fig.19B). The application of 150 µM diazoxide 
inhibited oscillatory activity completely (n=13) whereas the additional application 
of 300 µM tolbutamide restored electrical activity (n=13) (Fig.19B). The results 
clearly demonstrated that the BetaScreen prototype electrode revealed the same 
electrophysiological results as the previously used standard MEAs. Further, the 
results are qualitatively in line with the results obtained with other electrophysio-
logical recording techniques such as e.g. intracellular microelectrode recordings. 
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Fig.19: Glucose concentration response curve and pharmacological modulation 
of electrical activity with the KATP channel modulators diazoxide and tolbutamide. 
A Glucose concentration response curve plotted as FOPP [%] against glucose concen-
tration [mM] recorded with the BetaScreen prototype displays a similar electrophysiolog-
ical result as recorded with the standard MEAs. The half-maximal activity of 12.26 ± 2 
mM is comparable and the shape of the concentration curve has the expected sigmoidal 
shape B Recording of electrical activity in 10 mM glucose (FOPP in % = 83) with a neg-
ative positioning pressure of 10 mbar. The application of 150 µM of the KATP channel 
modulator diazoxide (n=13) inhibit electrical activity completely (FOPP in 5 = 0), whereas 
an additional application of 300 µM tolbutamide transiently restored the activity (FOPP 
in % = n/a). 
3.6 Expansion of the BetaScreen device to five recording 
chambers to increase the throughput of the recordings 
The next important step was to increase the throughput of the BetaScreen device 
to enable parallel recordings. Thus a complete redesign of the previously used 
MEA was necessary. The new designed chip consists of five recording chambers 
with five electrodes in each chamber (see Fig.20). The new layout of the MEA 
enables to record electrical activity from 25 intact islets simultaneously. The new 
MEA chips consist of a pottery substrate which has five holes with a diameter of 
5 mm. The holes are covered with a polyimide foil. The recording electrodes with 
the positioning holes are placed on the polyimide foil, so that each of the five 
holes contains five recording electrodes (see Fig.20). 
On top of the pottery substrate (MEA surface) is a so called multiwell cover ar-
ranged (see Fig.21). The multiwell cover with his five recording chambers is ap-
plied with glue on top of the MEA. Each of the five chambers can be perfused 
independently. For a proper and leak protected placement of the MEA into the  
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Fig.20: Schematic figure of the new BetaScreen MEA layout. A Total view of the 
BetaScreen MEA with contact pads and five recording chambers (see black arrows) B 
Magnification of a recordings chamber with five recording electrodes surrounded by po-
sitioning holes (see black arrows). 
headstage an additional substrate is glued onto the bottom of the MEA (see Fig. 
21). Moreover, the bottom substrate contains the connection for the perfusion 
system (influx and efflux) and as well the connection to the vacuum pump for the 
generation of suction. Figure 21Bc and d shows the fitting of the bottom substrate 
pins into small holes with integrated seals located in the headstage. 
 
Fig.21: Layout of the multiwell cover, assembling of the MEA with the multiwell 
cover and the integration into the amplifier unit. A CAD-drawing of the multiwell 
cover. (Left) Top view of the multiwell cover with the five oval recording chambers in the 
centre of the drawing. (Right) 3-D view of the cover unit Ba The multiwell cover with five 
recordings chambers and the bottom substrate (b) is glued on both sides of the MEA. 
The five chambers can be perfused independently. Influx and efflux of the perfusion sys-
tem and the connection to the vacuum pump is integrated. Bc and d The connection 
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between the MEA and the headstage unit is obtained via pins of the bottom substrate 
which stick into small holes located on the headstage. Leakage protection is gained with 
integrated seals.  
Figure 22 shows the BetaScreen in use during an experiment. The microscopic 
photos shows the five independent recording chambers numbered from 1 till 5. 
The electrodes in recording chamber 2 till 5 are covered with islets. A screenshot 
of the recording software (MC_Rack, Multi Channel Systems, Reutingen) dis-
plays the measurements. The red-rimmed rectangles mark the corresponding 
electrodes of each recording chamber. Electrical activity was induced by 10 mM 
glucose and 12 islets displayed oscillatory activity. The new developed five cham-
ber BetaScreen MEA enabled to record statistically signals from 4.6 ± 0.33 (n=32) 
chambers per recording. Within a single chamber the success rate reached an 
average of 2.9 ± 0.24 (n=57) islets per recording. At this stage of the BetaScreen 
development the throughput of the recordings could be increased by a factor of 
13.34 in comparison to the previous used acute recording technique.  
 
Fig. 22: Exemplary experiment with the newly developed BetaScreen device. The 
photos are showing the five recording chambers (1 to 5). In chamber 2 till 5 the electrodes 
are covered with islets. The screenshot shows the recording software and the red-
BetaScreen device    56 
rimmed rectangles are displaying the corresponding electrodes of each chamber. Elec-
trical activity was induced by 10 mM glucose and 12 islets displayed oscillatory activity. 
Note, the current layout of the BetaScreen allows to record electrical oscillations from up 
to 25 intact islets simultaneously. 
In conclusion, this study shows the successful development of a parallelised MEA 
chip, which allows to record simultaneously electrical oscillations from up to 25 
intact islets of Langerhans. The multi well cover on top of the new chip consists 
of five recording chambers, each chamber contains five electrodes. Each of the 
five chambers can be perfused independently. During the last phase of the project 
a success rate of almost 54% was reached, i.e. an average of 13.34 islet record-
ings per experiment. This is an improvement of throughput by a factor of 13.34 
compared to the acute recordings at the beginning of the project. The validation 
of the BetaScreen device revealed positive results. The properties of the electri-
cal activity are comparable to literature as well as to the acute recordings ob-
tained with the classical MEA chips. 
The BetaScreen device is an innovative new method which will facilitate the de-
velopment of new pharmacological substances in the field of diabetes research 
based on electrical activity. Previous attempts to use electrophysiological fea-
tures as readout for a higher throughput screening failed because of technical 
limitations, e.g. the invasiveness of the methods and the need of high technical 
skills. The BetaScreen device enables for the first time acute electrophysiological 
medium throughput recordings of whole intact islets. Moreover, it will facilitate 
basic research, e.g. in combination with knockout mice. Importantly, the capability 
to record also human islets (see chapter 2.4) opens numerous new possibilities 
for this approach, e.g. the system could be used as a quality control system prior 
to transplantation of human islets into patients with type-1-diabetes.  
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Long-term culture and functionality of pancreatic
islets monitored using microelectrode arrays
Sven Schönecker,a Udo Kraushaar,a Martina Düfer,b Anika Sahr,c Carmen Härdtner,c
Elke Guenther,a Reinhard Walther,c Uwe Lendeckel,c Winfried Barthlen,d
Peter Krippeit-Drewse and Gisela Drews*e
Extracellular recording of the glucose-induced electrical activity of mouse islets of Langerhans on
microelectrode arrays (MEAs) is an innovative and powerful tool to address beta-cell (patho-)physiology. In
a dual approach we tested whether this technique can detect concentration-dependent drug effects as
well as characterize alterations in beta-cell activity during prolonged culture. First we established conditions
that allow long-term investigation of beta-cell function by recording electrical activity. The results provide
the first measurements of beta-cell membrane potential oscillations of individual murine islets during long-
term culture. Oscillations were recorded for up to 34 days after islet isolation. Importantly, the glucose
dependence of electrical activity did not change over a period of one month. Thus we can follow
electrophysiological changes of individual islets induced by alterations in the beta-cell environment over
weeks. Second, we used the MEA technique to assay beta-cell damage induced by oxidative stress and to
evaluate appropriate protection mechanisms. Oxidative stress plays a key role in the development of type
2 diabetes mellitus (T2DM). Examination of the acute effects of H2O2 on electrical activity showed that the
oxidant reduced the electrical activity in a concentration-dependent manner. The superoxide dismutase
mimetic, tempol, protected against the detrimental effects of H2O2. In conclusion, we demonstrated
that MEA recordings can be used to address disease-related mechanisms and protective interventions in
beta-cells. In the future, this fundamental work should enable the monitoring of the electrical activity of
islets of Langerhans under controlled ex vivo conditions including long-term exposure to oxidative
stress, glucolipotoxicity, and other diabetes-inducing agents.
Insight, innovation, integration
Type-2 diabetes mellitus (T2DM) is a tremendous health problem worldwide. Our work demonstrates that the microelectrode array (MEA) technique is an
excellent tool to study in vitro the molecular basis of functional changes in beta-cells occurring during the development of type 2 diabetes mellitus. First, we
established an in vitro model that allows long-term investigation of beta-cell function by registration of the electrical activity of isolated islets using the MEA
technique. In the second step we applied oxidative stress to the islets which is crucial in the development of T2DM and evaluated appropriate protection
mechanisms. This is a fundamental study that enables monitoring the electrical activity of murine islets in controlled ex vivo situations during long-term
exposure to defined diabetes-associated, e.g. oxidative stress, glucolipotoxicity, and diabetes-inducing agents.
Introduction
Insulin secretion of pancreatic beta-cells is determined by the degree
of electrical activity, i.e. phases of depolarized membrane potential
with action potentials and repolarized interbursts. Recently, we
succeeded in recording the electrical activity of isolated mouse islets
of Langerhans using planar, extracellular electrodes arranged in
a microelectrode array (MEA).1 This approach was confirmed by
Raoux and coworkers.2 The MEA system allows quantifying the
electrical activity of beta-cells by calculating the fraction of the
plateau phase (FOPP, the percentage of time with spike activity).
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We demonstrated that the glucose dependence of the FOPP
measured using a MEA equals that measured using sharp intra-
cellular microelectrodes and is almost identical with the glucose
dependence of insulin secretion measured with isolated mouse
islets.3 In addition, the MEA technology enables detection of the
first phase of electrical activity elicited by an increase in glucose
from a sub-stimulatory to a stimulatory concentration and allows
simultaneous measurement of fluctuations in electrical activity
and cytosolic Ca2+ concentration.1
These results convincingly demonstrate that MEAs are excellent
and unique tools for reliable measurements of the FOPP. MEAs are
superior to conventional electrophysiological methods since they are
(1) non-invasive, (2) use whole islets that – in contrast to single cells –
consistently display oscillations of electrical activity, and (3) easy to
handle, thus increasing the experimental throughput enormously.
In humans, T2DM develops over many years. Current in vitro
models to investigate alterations in the oscillatory activity of
pancreatic islets seldom exceed a time period of several hours
and are thus inadequate to study long-term changes. We demon-
strate, for the first time, that the MEA approach allows monitoring
of electrical activity and glucose-responsiveness of cultivated
islets over a period of weeks. Increased oxidative stress within
beta-cells due to excessive fuel intake or increased hormone levels
(e.g. angiotensin II, endothelin) is a key event in the development of
T2DM.4 Since antioxidant defence mechanisms are low in beta-
cells the characterization of strategies to prevent oxidative stress is a
promising approach to identify beta-cell protective drugs. It is well
known that oxidative stress reduces or even completely prevents
glucose-mediated alterations in electrical activity,5 thus the ability
to make extended electrical measurements is attractive. We show
that the MEA technology is very sensitive, allows detection of small
changes in electrical activity caused by acute treatment of islets
with an oxidant and can be used to determine the protective effect
of a drug mimicking superoxide dismutase.
Taken together, we demonstrate the suitability of the MEA-
based approach (1) to develop in vitro models for the study of
long-term changes in islet function, (2) to investigate effects of
diabetes-promoting conditions, i.e. oxidative stress, and (3) to
test strategies for protection of islets against diabetes-associated
functional cell damage.
Research design and methods
Islet preparation
Experiments were performed using intact islets of Langerhans
isolated from adult C57Bl/6N mice (Janvier, France). The principles
of laboratory animal care were followed according to German laws.
Mice were euthanized by CO2. Islets were isolated by collagenase
digestion of the pancreas and cultured up to 34 days in RPMI 1640
medium supplemented with 10% fetal calf serum, 100 U ml1
penicillin and 100 mg ml1 streptomycin.
Solution and chemicals
Measurements of extracellular membrane potential were
performed at 37 1C in a solution containing in mM: 140 NaCl,
5 KCl, 1.2 MgCl2, 2.5 CaCl2, 10 HEPES, pH 7.4, and glucose as
indicated. The incubation medium for determining insulin
secretion contained (in mM): 122 NaCl, 4.8 KCl, 2.5 CaCl2,
1.1 MgCl2, 10 HEPES, pH 7.4. RPMI 1640, fetal calf serum, and
penicillin/streptomycin were provided by Invitrogen (Karlsruhe,
Germany). All other chemicals were purchased from Sigma-
Aldrich (Taufkirchen, Germany), Roth (Karlsruhe, Germany) or
Merck (Darmstadt, Germany).
Recording setup for measuring membrane potential using
extracellular electrodes
Extracellular membrane potential recordings were obtained
with the MEA technique6 using a MEA 1060-inv-standard
amplifier system and software MC-Rack (Multi Channel Systems
(MCS), Reutlingen, Germany). Data were low-pass filtered at 25 Hz
and sampled at 1 kHz. Titanium-nitride electrodes had a diameter of
30 mm (200/30-Ti; MCS). In experiments with acute application of
drugs one islet was placed on one of the 64 electrodes by means of a
glass holding pipette with a tip angle of 301 (Reproline, Rheinbach,
Germany) and a micromanipulator (Eppendorf, Hamburg,
Germany). Extracellular voltage changes were only recorded from
the electrode where the islet was placed using the grounded bath
electrode as in ref. 1. In long-term culture experiments several
islets were placed on different electrodes within the array.
Experimental procedure for measuring extracellular membrane
potential
For acute drug application islets were used after 1–3 days of culture.
Islets were incubated at 3 mM glucose for 10 to 20 min prior to
experiments. Single islets were then transferred to the MEA bath
chamber using a holding pipette and fixed to an electrode with
gentle mechanical pressure. The islet was continuously perifused
with bath solution throughout the experiment. Recordings always
started in 3 mM glucose which gave a base-line with no electrical
activity. Oscillatory activity was usually followed for 30–45 min for
each condition and evaluated at periods of steady-state oscillations
for the last 5–10 min before a new manoeuvre started. For long-term
culture experiments the islets were kept in culture medium (RPMI,
11.1 mM glucose) on the MEA for the indicated time period. The
culture medium was changed every second day. Each experiment
started in culture medium before changing to the bath solution. For
quantification of electrical activity the fraction of the plateau phase
(FOPP) was determined by dividing a distinct time interval by the
time with bursting activity within this distinct time interval.
Measurement of insulin secretion
After preparation islets were kept overnight in medium supple-
mented with 11.1 mM glucose. To determine insulin secretion,
batches of 5 islets were incubated for 60 min at 37 1C with the
indicated substances. Insulin was determined by radioimmunoassay
using rat insulin (Crystal Chem. Inc., USA) as the standard.
Presentation of results
The recordings are representative of results from different
islets; islets from at least 3 different mice were used for each
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indicated number of experiments. Statistical significance was
assessed by ANOVA followed by the Student–Newman–Keuls
post-test. A value of p r 0.05 was considered to be significant.
Results and discussion
Long-term measurements of beta-cell electrical activity
To study the effects of a diabetes-promoting environment, e.g.
ROS, on the electrical activity of mouse beta-cells in more
detail, it would be of great advantage to record changes over
several days. However, all current electrophysiological techniques
used in beta-cell research provide only short-term measurements
of electrical activity, i.e. a range of minutes, or in exceptional
cases, hours. In experiments with conventional microelectrodes
or patch-clamp experiments the membrane potential measure-
ment is regularly disturbed by leakage currents. Moreover, it is
not possible to study the electrical activity of the same islet on
different days. Therefore, we developed a system allowing long-
term culture of isolated islets and, most importantly, regular
measurements of the electrical activity of individual islets during
culture. We validated physiological dynamics, i.e. the glucose
responsiveness of the islets cultured on the MEA in the presence
of 11.1 mM glucose and the appearance of oscillations over
several weeks. As shown in Fig. 1A islets maintain their ability
to respond adequately to glucose with oscillations up to 34 days.
It was possible to record independent electrical activity simulta-
neously from several islets in contact with different electrodes on
the MEA. Thus, the rate of successful experiments was increased
compared to conventional electrophysiological methods.
As observed in acute experiments, at 3 mM glucose no oscilla-
tions were detected even after 34 days of culture. Differences in
the oscillations induced by 10 or 15 mM glucose, respectively,
could be distinguished over time in the culture showing that
the glucose dependence of electrical activity was preserved
over several weeks (Fig. 1B). The data indicate that glucose
metabolism is intact after long-term culture. The FOPP at
10 and 15 mM glucose, respectively, did not change over time.
To evaluate possible culture time-dependent changes in elec-
trical activity, the FOPP was summarized for experiments
measured in the first week of culture (day 6 and 7) and
compared with experiments performed in the last culture week
(day 33 and 34). The FOPP amounted to 32  3% (n = 8) and
36  2% (n = 7) at 10 mM glucose and to 70  6% (n = 8) and
72  5% (n = 7) at 15 mM glucose at day 6/7 and day 33/34,
respectively. The data clearly demonstrate that the FOPP at
10 and 15 mM glucose, respectively, did not change over time in
culture. Notably, the number of non-responding islets is
negligible with the MEA technology in contrast to microelectrode
impaling. This paves the way to perform long-term experiments
of electrical activity with low concentrations of redox-active
compounds or diabetes-inducing agents and to study progres-
sive changes evoked by gluco-, lipo- or glucolipotoxicity. Raoux
and coworkers reported reduced action potential frequency of
clonal INS-1E cells kept on a MEA after 3 days at elevated
glucose concentration.2 Moreover, the method permits co-culture
of islets with other tissues to investigate their influence(s) on
electrical activity.
In summary, the data presented show that MEA technology
offers numerous novel and interesting long-term applications
in beta-cell research, e.g. investigation of chronic effects of diabetes-
inducing environments on electrical activity or the development of
an in vitro model for testing short and long-term effects of potential
antidiabetic drugs.
MEA technology detects protection against oxidative stress-
induced pathophysiological changes of beta-cell electrical
activity
Oxidative stress is an important pathogenic factor that con-
tributes to the development of T2DM.4a We have shown that
up-regulation of the antioxidant enzymes catalase (Cat),
glutathione peroxidase (Gpx) and superoxide dismutase (SOD)
in primary mouse beta-cells protects against apoptosis and loss
of beta-cell function, respectively, that was induced by oxidative
stress5a This is in agreement with observations of Lortz and
co-workers who showed that overexpression of antioxidant enzymes
reduces cytokine-induced cytotoxicity in insulin-secreting RINm5F
cells.7 H2O2 is one of the reactive oxygen species markedly
contributing to oxidative stress in pancreatic islets. It is known
to interact with several parameters of beta-cell stimulus-secretion
coupling.8 In the present study we investigated H2O2-evoked
changes in electrical activity of mouse beta-cells and tested whether
the membrane-permeable SOD mimetic, tempol,9 protects
beta-cells against H2O2-induced insult. First, we applied differ-
ent concentrations of H2O2 in the presence of 10 mM glucose
resulting in concentration-dependent inhibition of the FOPP
that was well resolved by the MEA technology (Fig. 2A and B).
Second, islets pre-incubated at 1 mM tempol prior to the
Fig. 1 Electrical activity of isolated mouse islets in long-term culture in
the presence of 11.1 mM glucose. (A) Typical recordings showing electrical
activity induced by 10 and 15 mM glucose and lack of activity in bath
solution with 3 mM glucose after 6 and 34 days of culture. (B) Quantifica-
tion of the FOPP in the presence of 10 and 15 mM glucose for different
days of culture. *P r 0.05, **P r 0.01, ***P r 0.001. Statistical differences
between the FOPP at 10 and 15 mM glucose at each culture day. The
n-values within the columns indicate the number of islets. 5 different
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addition of 300 mM H2O2 were compared to those exposed
solely to 300 mM H2O2. To avoid direct interaction of tempol
and H2O2, tempol was removed immediately before addition of
H2O2. H2O2 significantly reduced the FOPP in the presence of
10 mM glucose but was without effect after 30 min of pre-
incubation with 1 mM tempol (Fig. 2C and D). The SOD
mimetic exerted a protective effect against the reduction of
insulin secretion by 100 mM H2O2. In experiments without pre-
treatment insulin secretion was reduced, but was unchanged
after 15 min pre-incubation with the SOD mimetic (Fig. 2E).
Tempol alone did not influence insulin secretion (2.91 
0.36 ng insulin per islet per h in the presence of 15 mM glucose
vs. 3.18  0.29 ng insulin per islet per h in the presence of
15 mM glucose and tempol; n = 4; n.s., not shown). The different
efficacy of H2O2 on insulin secretion and electrical activity is most
likely due to differences in diffusion in the two measurement
systems (1 h steady-state incubation for insulin secretion vs.
perifusion for the measurement of electrical activity). The results
clearly demonstrate that tempol preserves insulin secretion by
circumventing the detrimental effect of H2O2 on stimulus-
secretion-coupling. This agrees with our previous observations that
up-regulation of antioxidant enzymes protects beta-cells against
oxidative stress.5a The new data also show that the SOD plays a
crucial role in the antioxidant defence of beta-cells and seems to be
more important than Cat and Gpx since an SOD mimetic alone is
sufficient to protect against an oxidative insult. At first glance it
seems astonishing that an SOD mimetic protects electrical activity
and insulin secretion against H2O2 since SOD does not degrade
H2O2. It is assumed that tempol-dependent protection of the islets
is due to detoxification of H2O2-induced ROS production including
O2
. First, H2O2 leads to a partial depolarization of the mitochon-
dria5b and a decrease of the mitochondrial membrane potential is
assumed to increase ROS production. Second, ROS, including
H2O2, can induce mitochondrial ROS release.
10 This mechanism
has been extensively studied in cardiomyocytes and involves the
mitochondrial permeability transition pore and/or the anion
channel of the inner mitochondrial membrane. In both cases
formation of superoxide anions in the mitochondria would rise
and potentiate ROS generation and action. We suggest that this
vicious circle is stopped by the SOD mimetic.
We have shown that a SOD mimetic protects beta-cells
against acute oxidative stress pointing to the central role of
SOD in antioxidant defence of pancreatic islets. Our experi-
ments demonstrate that glucose-responsiveness of isolated
islets cultured on MEAs is stable for up to 34 days. These data
indicate that MEA technology is a valuable tool to investigate
long-term effects of drugs influencing beta-cells via membrane
potential-dependent pathways. The results suggest the feasi-
bility of developing MEA-based in vitro disease models where
islets are chronically challenged by glucolipotoxicity or stress-
inducing agents thus enabling evaluation of intervention
strategies.
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Abstract The membrane potential (Vm) of beta-cells oscil-
lates at glucose concentrations between ~6 and 25 mM, i.e.
burst phases with action potentials alternate with silent
interburst phases generating so-called slow waves. The slow
waves drive oscillations of the cytosolic Ca2+ concentration
([Ca2+]c) and insulin secretion. The length of the bursts
correlates with the amount of insulin release. Thus, the
fraction of plateau phase (FOPP), i.e. the percentage of time
with burst activity, is an excellent marker for beta-cell
function and metabolic integrity. Extracellular voltage
changes of mouse islets were measured using a microelec-
trode array (MEA) allowing the detection of burst and
interburst phases. At a non-stimulating glucose concentration
(3 mM) no electrical activity was detectable while bursting
was continuous at 30 mM. The glucose concentration–
response (determined as FOPP) curve revealed half-maximal
stimulation at 12±1 mM (Hill equation fit). The signal was
sensitive to KATP channel modulators, e.g. tolbutamide or
diazoxide. Simultaneous recordings of electrical activity and
[Ca2+]c revealed congruent bursts and peaks, respectively.
The extracellular recordings are in perfect agreement with
more time-consuming intracellular electrical recordings. The
results provide a 'proof-of-principle' for detection of beta-cell
slow waves and determination of the FOPP using extracel-
lular electrodes in a MEA-based system. The method is
facile and provides the capability to study the effects of
modulators of beta-cell function including possible anti-
diabetic drugs in real time. Moreover, the method may be
useful for checking the metabolic integrity of human donor
islets prior to transplantation.
Keywords MEA . Extracellular recording . Islet . Slow
waves . KATP channel . Insulin secretion
Introduction
The early work of Dean and Matthews [4] established that
pancreatic beta-cells are electrically excitable. The beta-cell
membrane potential (Vm) exhibits slow waves of electrical
activity [7], consisting of bursts of Ca2+ action potentials
and silent interburst phases. This fluctuating electrical
activity actuates slow oscillations of [Ca2+]c [18] and
insulin secretion [2, 10]. The fraction of plateau phase
(FOPP) is an excellent marker for intact beta-cell function
and metabolism [7].
Before the introduction of the patch-clamp technique the
determination of FOPP required measuring with sharp
microelectrodes to elucidate electrical properties of beta-
cells [7, 12, 13]. Both electrophysiological methods are
technically demanding and are too time consuming to be
used routinely. Moreover, it is difficult to detect Vm
oscillations of single or small beta-cell clusters with
patch-clamping [6, 11, 15] although slow waves are
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invariably detectable when intact islets with electrically
coupled cells are impaled by intracellular microelectrodes
[6]. To circumvent this problem Göpel and co-workers
developed a technique to patch-clamp whole islets [11], but
the method is technically challenging and time consuming.
Different patterns of [Ca2+]c oscillations between single
cells and islets have been reported [9] emphasizing that
measurement of oscillations from whole islets is more
reliable and closer to the in vivo situation.
Microelectrode arrays (MEAs) present an alternative
way to study the electrical activity of single cells or
tissue slices and have been used successfully on cells
from the heart, central and peripheral nervous system,
and muscles [14, 20]. Data on the use of extracellular
electrodes to record electrical activity from islets are
scarce [3, 17] possibly because these attempts did not
successfully resolve slow wave oscillations. Here we
report on a non-invasive MEA-based system for the
detection of glucose-induced slow waves in islets. This
report is the 'proof-of-principle' for a method which can be
extended for low-throughput to medium-throughput
screening and thus allow the routine use of islets of
Langerhans in industrial research. Additionally, the method is
applicable to testing the metabolic status of human donor
islets prior to transplantation.
Research design and methods
Islet preparation
Experiments were performed using intact islets of Langerhans
isolated from adult C57Bl/6 N or NMRI mice (Janvier,
France). The principles of laboratory animal care were
followed according to German laws. Mice were euthanized
by CO2 application. Islets were isolated by collagenase
digestion of the pancreas and cultured up to 3 days in RPMI
1640 medium supplemented with 10% fetal calf serum,
100 U/ml penicillin and 100 μg/ml streptomycin.
Solution and chemicals
Measurements of [Ca2+]c, membrane potential changes by
MEA (both 37°C), and patch-clamp recordings (34°C) were
performed in a solution containing in millimolar: 140 NaCl,
5 KCl, 1.2 MgCl2, 2.5 CaCl2, 10 HEPES, pH 7.4, and
glucose as indicated. Recordings of Vm with microelectr-
odes were done in a bath solution composed of (in
millimolar): 120 NaCl, 5 KCl, 2.5 CaCl2, 1.2 MgCl2, 24
NaHCO3, 15 glucose, aerated with 95% O2 and 5% CO2 to
maintain a pH of 7.4 at 37°C.
RPMI 1640, fetal calf serum, penicillin/streptomycin,
and fura-2 were provided by Invitrogen (Karlsruhe,
Germany). All other chemicals were purchased from
Sigma-Aldrich (Taufkirchen, Germany), Roth (Karlsruhe,
Germany), or Merck (Darmstadt, Germany).
Recording setup
Extracellular membrane potential recordings were obtained
with the microelectrode array (MEA) technique [20] using a
MEA USB-1060 system with software MC-Rack (Multi
Channel Systems (MCS), Reutlingen, Germany). Data were
low-pass filtered at 70 or 100 Hz and sampled at 10 kHz.
Titanium-nitride electrodes had a diameter of 30 μm (200/
30-Ti; MCS). An islet was placed on one of the 59
electrodes by means of a glass holding pipette with a tip
angle of 30° (Reproline, Rheinbach, Germany) and a
micromanipulator (Eppendorf, Hamburg, Germany). Extra-
cellular voltage changes were only recorded from the
electrode where the islet was placed on (Fig. 1c) using the
grounded bath electrode as reference.
Equipment and software for patch-clamp recordings and
fluorescence measurements were from HEKA (Lambrecht,
Germany) and from TILL photonics (Gräfelfing, Germany),
respectively.
Electrophysiological experiments
Islets with a diameter of ~150 μm (Fig. 1a) were used
for experiments after 1–3 days in culture. Islets were
incubated in 3 mM glucose for at least 30 min prior to
experiments. Single islets were then transferred to the
MEA bath chamber (Fig. 1b, c), using a holding pipette
with a negative pressure of about −15 mbar and fixed to an
electrode with gentle mechanic pressure. The islet was
continuously perifused with bath solution throughout the
experiment. Recordings always started in 3 mM glucose
cba
100 µm50 µm 1 cm
Fig. 1 a Microscopic view of a
single murine islet of Langer-
hans. b A microelectrode array
(MEA, Multi Channel Systems).
c Islet of Langerhans placed on
top of a MEA electrode
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which gave a base-line with no electrical activity.
Oscillatory activity was usually followed for 30–45 min
for each condition and evaluated at periods of steady-state
oscillations for the last 5–10 min before a new manoeuvre
started.
Patch-clamp and intracellular microelectrode recordings
were performed according to Düfer et al. [8]. [Ca2+]c was
determined as the ratio of fura-2 fluorescence at 360-nm
and 380-nm excitation wavelength. The MEAwas mounted
on an inverted microscope (Zeiss, Stuttgart, Germany), and
a pair of images was taken every 10 s. Because the glass of
the MEA absorbed too much light at 340 nm, 360 nm
excitation was used. The large difference in the ratios of the
[Ca2+]c measurements between the experiments shown in
Fig. 5 is presumably due to different absorption of light by
the MEA since the islets were covered to a different extent
by the electrode and/or conductor traces (cf. Fig. 1c).
Presentation of results
The recordings are representative of results from different





















Fig. 2 Extracellular recordings with the MEA technique (a, c) and
intracellular recordings obtained using the perforated-patch technique
(b, d) at 15 mM glucose. a, b Single burst of APs of beta-cells in an
islet. Note that the AP voltage deflections are negative or positive
when measured extracellularly or intracellularly. c, d Four consecutive
oscillations in 15 mM glucose. Representative recordings for





















Fig. 3 Electrical activity in-
duced in beta-cells by an in-
crease in glucose concentration
from 3 to 15 mM. One repre-
sentative of eight extracellular
recordings (a) is compared to
one of three intracellular micro-
electrode recordings (b). Note
that in both measurements the
first phase with a long burst is
followed by a longer interburst.
The second phase consists of
more or less regular oscillations.
In c the effect of 100 μM
diazoxide and the additional
application of 150 μM tolbuta-
mide (indicated by horizontal
bars) on an extracellular re-
cording of an islet in 15 mM
glucose is shown. One of eight
experiments with similar results
Pflugers Arch - Eur J Physiol
series of experiments. Values are given as means±SEM for
the indicated number of experiments. Statistical signifi-
cance was assessed by ANOVA followed by the Student–
Newman–Keuls post-test. A value of p≤0.05 was considered
to be significant.
Results
To investigate whether a MEA-based setup can reliably
detect the electrical activity of intact islets of Langerhans,
extracellular recordings were compared to intracellular
measurements obtained by traditional techniques.
Figure 2a, c displays traces measured with the new MEA
technique, while traces in Fig. 2b, d show intracellular
recordings obtained with the perforated-patch technique.
Figure 2a, b shows one burst of glucose-induced Ca2+
action potentials (APs) at an expanded time scale. Since the
changes of Vm shown in Fig. 2a are measured by
extracellular electrodes, the AP voltage deflection is
negative with reference to the grounded bath electrode.
Thus, this recording reflects to a first approximation the
negative of the first derivative of APs measured with
intracellular electrodes which are by definition positive
voltage deflections (Fig. 2b).
Figure 2c, d shows that glucose-induced slow waves of
mouse beta-cells exhibit similar patterns of electrical
activity regardless of whether they are recorded by MEAs
or intracellular techniques. Obviously the time course of
the slow waves is different (note different time scales).
This is presumably due to differences between individual
islets. While the variation in individual burst and inter-
burst times between different islets may be large, the
relationship between both, i.e. the FOPP at a given
glucose concentration, varies only in a narrow range. In
addition, it may be that invasive electrodes induce a
depolarising leakage current which makes the bursting
faster. Figure 2c shows that the time resolution of
extracellular recordings is sufficient to clearly discriminate
burst and interburst phases and enable the determination
and calculation of FOPP.
According to the consensus model of the stimulus-secretion
coupling, electrical activity starts as soon as the ATP
concentration close to the KATP channels is sufficiently
increased to affect the channel activity [1, 19]. The glucose-
induced ATP production of metabolically intact beta-cells
leads to closure of KATP channels and as a consequence to the
depolarization of Vm [1, 7, 12]. Typically, a biphasic rise of Vm
with a first phase characterized by a very long burst followed
by an extended silent period is observed. In the second phase
the typical oscillations of Vm occur. Figure 3a, b illustrates
that this characteristic pattern of electrical activity is obtained
with both, extracellular (MEA) and intracellular (micro-
electrodes) measurements. Again the burst duration in these
examples is different, but a similar FOPP can be obtained in
the second phase. Thus, the metabolic integrity of an islet can
be estimated by extracellular measurements of changes in Vm.
Figure 3c shows the electrical activity (slow waves) of
an islet in 15 mM glucose recorded with extracellular MEA
electrodes which can be silenced by the addition of the
KATP channel opener diazoxide (100 μM) and that APs
































Fig. 4 a, b Representative MEA recordings from islets in 10 or
15 mM glucose. c Glucose concentration–FOPP curve measured with
MEA electrodes. Data are means±SEM for 3 mM (n=10), 6 mM (n=
5), 8 mM (n=5), 10 mM (n=8), 15 mM (n=11), and 30 mM (n=5)
glucose, respectively. The data are fitted with the Hill equation (dotted
line) giving a half-maximal glucose concentration of 12±1 mM. All
values are significantly different from each other (p≤0.05) except









































Fig. 5 a, b Two examples of simultaneous recordings of electrical
activity and [Ca2+]c. The upper traces show glucose-induced electrical
activity, and the lower traces are measurements of [Ca2+]c. Note that
each burst of APs is accompanied by a peak in [Ca2+]c. The glucose
concentration was 10 mM
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Figure 4 shows the glucose dependency of the FOPP
recorded with MEA electrodes. Traces in Fig. 4a, b show
representative recordings in 10 mM and 15 mM glucose.
The glucose concentration–response curve of the FOPP
provides values of 0% (no activity) for 3 mM glucose
(n=10) or 100% (continuous spiking) for 30 mM glucose
(n=5). Consistent with values for intracellular recordings
[12] the FOPP increased to 22±3% (n=5), 36±4% (n=5),
38±3% (n=8), and 56±4% (n=11) with 6, 8, 10, and 15 mM
glucose, respectively. Fitting a Hill equation to these data
(Fig. 4c) revealed half-maximal activity (50% FOPP) for
12±1 mM glucose which is close to the value of 11 mM
glucose measured with intracellular microelectrodes [12].
In 1991 Santos and co-workers [18] have shown that
simultaneous measurements of Vm with intracellular elec-
trodes and [Ca2+]c exhibit synchronous oscillations. Figure 5
compares electrical measurements by extracellular record-
ing with [Ca2+]c. Two examples are given (Fig. 5a, b)
respectively; the upper traces show glucose-induced elec-
trical activity, and the lower traces are measurements of
[Ca2+]c. Each burst of action potentials is accompanied by a
peak in [Ca2+]c.
Discussion
Pancreatic beta-cells are unique as they exhibit oscillatory
electrical activity known as slow waves in response to glucose
[7]. The FOPP rises proportional to the glucose concentra-
tion within a range between ~6 and 25 mM with a half-
maximum response of approximately 11 mM [12]. At
concentrations >25 mM continuous action potential firing
occurs whereas at lower glucose concentrations
(<6 mM) beta-cells are electrically silent [7]. Extracellular
MEA recordings from whole islets exhibit the same glucose
dependence (Fig. 3). Thus, possible contamination from the
electrical activity of alpha-cells that exhibit the opposite
glucose dependence, i.e. activation at low and inhibition at
high glucose [7], is negligible. This can be explicitly seen in
Fig. 3a where the glucose concentration was changed from 3
to 15 mM. If alpha-cell electrical activity contributed to the
background noise seen in 3 mM glucose, it should be
silenced when the glucose concentration was increased (just
before beta-cells were activated), but no change was detected
in this and similar experiments.
The detection of islet cell electrical activity by extracel-
lular electrodes has been reported so far by two groups [3,
17]. To our knowledge this is the first demonstration of
glucose-induced slow waves and the first calculation of the
glucose dependence of FOPP using MEA technology.
As [Ca2+]c [18] and importantly insulin secretion [2, 10]
are coupled directly to the fraction of time beta-cells are
bursting, FOPP provides an excellent marker for the actual
insulin release from islets in response to glucose and/or test
substances. Two examples (see Fig. 5) illustrate the close
coupling between bursts measured with extracellular elec-
trodes and [Ca2+]c. Every burst of action potentials
produces a rise in [Ca2+]c as previously shown for
simultaneous measurements with microelectrodes and Ca2+
imaging [18]. Thus, determining FOPP with an extracellular
microelectrode array provides a facile means to estimate
insulin release in real time in response to various stimuli.
Compared to patch-clamp or Ca2+ measurements by fluores-
cence techniques the method has the advantage to be non-
invasive. Other types of cells and tissue slices have been
maintained on MEAs for long periods; [14] thus, the method
offers the possibility of recording from the same islet
multiple times at intervals of hours or days. Therefore,
MEAs allow recording of both acute changes of beta-cell
electrical activity and the chronic effects of metabolites or
drugs. MEAs should be useful for investigating co-cultures,
e.g. how co-culturing pig islets with spleen cells affects
insulin secretion [21] or how bone marrow increases the
survival time of human islets [16]. MEAs could be used to
study co-cultures of macrophages and islets and determine
the action of macrophage-released substances on beta-cell
electrical activity.
Finally, MEA technology can be applied to human
islets. A screening system allowing the simultaneous
measurement of oscillating insulin secretion by up to 15
single islets has been published recently [5], but the
required manual encapsulation of single islets and the use
of specifically labelled insulin, insulin antibody, and a
means of fluorescence detection make the assay techni-
cally difficult.
We have provided a "proof-of-principle" that FOPP can
be measured using single islets and extracellular electrode
arrays. These arrays have multiple electrodes which can be
recorded from independently; thus, it is feasible to develop
low-throughput to medium-throughput assay systems where
the electrical activity of 50 or more islets can be measured
simultaneously. This would provide an ideal tool to
evaluate the metabolic state of primary islets of Langerhans
and to test the effects of metabolites, cytokines, drugs, and
co-cultured cells.
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Introduction
▼
This study depicts a proof of principle that it is 
possible to measure oscillatory electrical activity 
of human islets with extracellular electrodes. The 
formation of glucose-induced oscillations of the 
plasma membrane potential Vm in beta-cells is a 
matter of interest for more than 25 years [1]. We 
have shown previously that recording of electri-
cal activity with extracellular electrodes on 
micro-electrode arrays (MEA) is an excellent and 
easy-to-use tool to evaluate beta-cell function of 
mouse islets [2, 3]. The percentage of time with 
burst activity, the so-called fraction of plateau 
phase (FOPP), is glucose-dependent and deter-
mines the amount of insulin secretion [1, 4]. 
Metabolism-dependent closure of KATP channels 
and the subsequent membrane depolarisation, 
the so-called stimulus-secretion coupling of 
human beta-cells seems to be not very different 
to rodents [5]. Human beta-cells even exhibit a 
similar pattern of electrical activity, consisting of 
bursts of action potentials (APs) and silent inter-
bursts [5], the so-called slow waves [1]. Although 
the initiation of the first burst of APs is similar in 
human and mouse beta-cells, the AP generation 
and burst termination may differ in some 
respects between the 2 species [5–8].
We show here that glucose-induced electrical 
activity of isolated human islets can be resolved 
and analysed with the MEA technique. We pro-
pose that the non-invasive extracellular record-
ings can be seminal for human beta-cell research 
as it is a valuable tool to assess on-line the func-
tion of human islets and may allow research with 
only a few islets at a time, e. g., when the number 
of islets in a biopsy is limited. This first demon-
stration presents only some occasional measure-
ments and thus may be yet not more than a "case 
report", but it suggests that the method is suita-
ble to study factors which modify membrane 
oscillations of human islets. Furthermore, this 
non-invasive, increased throughput method will 
be useful to on-line assess the responsiveness of 




Human islets were obtained from biopsies taken 
during pancreatic surgery according to the 
approvals of the ethics commissions of the Medi-
cal Faculty and the University Hospital of the 
University of Tübingen (No. 359/2013BO2) and 
the Universitätsmedizin Greifswald (BB 050/13). 
Abstract
▼
This study demonstrates for the first time that 
the microelectrode array (MEA) technique 
allows analysis of electrical activity of islets 
isolated from human biopsies. We have shown 
before that this method, i. e., measuring beta cell 
electrical activity with extracellular electrodes, is 
a powerful tool to assess glucose responsiveness 
of isolated murine islets. In the present study, 
human islets were shown to exhibit glucose-
dependent oscillatory electrical activity. The 
glucose responsiveness could be furthermore 
demonstrated by an increase of insulin secre-
tion in response to glucose. Electrical activity 
was increased by tolbutamide and inhibited by 
diazoxide. In human islets bursts of electrical 
activity were markedly blunted by the Na +  chan-
nel inhibitor tetrodotoxin which does not affect 
electrical activity in mouse islets. Thus, the MEA 
technique emerges as a powerful tool to deci-
pher online the unique features of human islets.
Additionally, this technique will enable research 
with human islets even if only a few islets are avail-
able and it will allow a fast and easy test of meta-
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The islets were isolated by injecting collagenase (2–4 mg/ml, 
Serva , Heidelberg, Germany) into the biopsy material and by 
handpicking after digestion at 37 °C. Islets from mice were iso-
lated as described previously [2]. For measuring electrical activ-
ity of human islets in pancreas slices a biopsy was embedded in 
4 % low-melting agarose. Slices of 300 µm thickness were cut 
with a Leica VT1000 S vibrating blade microtome (Leica, Wetz-
lar, Germany) Islets and pancreatic slices were cultured over-
night in RPMI 1640 (mice, 11 m M glucose) or in DMEM or 
CMRL1066 (human, 5 mM glucose). All media were supple-
mented with 10 % fetal calf serum, 100 U ml − 1 penicillin and 
100 µg ml − 1 streptomycin. The principles of laboratory animal 
care were followed according to German laws.
Recordings of extracellular membrane potential were performed 
at 37 °C in a solution containing in mM: 140 NaCl, 5 KCl, 1.2 
MgCl2, 2.5 CaCl2, 10 HEPES, pH 7.4, and glucose as indicated. All 
other chemicals were purchased from Sigma-Aldrich 
(Taufkirchen, Germany), Roth (Karlsruhe, Germany) or Merck 
(Darmstadt, Germany).
Extracellular membrane potential recordings were obtained 
with the MEA technique as described previously [2] using a MEA 
1060-inv-standard amplifier system and MC-Rack software 
(Multi Channel Systems (MCS), Reutlingen, Germany). Isolated 
islets were placed on an individual electrode within an electrode 
array, and extracellular voltage changes were recorded by this 
electrode. For measuring electrical activity of human islets in 
pancreas slices they were placed on the MEA by means of a plat-
inum grid. Islets or slices were continuously perifused with bath 
solution throughout the experiment.
For insulin secretion, batches of islets (10 islets/500 µl) were 
incubated in modified Krebs-Ringer-bicarbonate buffered saline 




Extracellular recordings of isolated human islets are not depend-
ing on the age of the donor.  ●▶ Fig. 1 shows MEA recordings from 
an adult donor ( ●▶ Fig. 1a,  > 60 years old) and from 2 children 
( ●▶ Fig. 1b, d,  < 1 year old), suffering from a pancreas tumour and 
congenital hyperinsulinism (CHI), respectively. The islet in  ●▶ Fig. 
1a was electrically silent in 1 mM glucose and started bursting in 
10 mM glucose. The sulfonylurea tolbutamide (100 µM) clearly 
increased the glucose-induced activity to almost continuous 
spiking ( ●▶ Fig. 1a). The islet shown in  ●▶ Fig. 1b responded to tol-
butamide (200 µM) in the presence of 10 mM glucose with spik-
ing at low frequency, but spiking could be inhibited by diazoxide 
Fig. 1 Electrical activity of human islets. a Electrical activity of an isolated human islet of 3 Langerhans received from an adult donor at different glucose 
concentrations and in 4 the presence of tolbutamide. b Electrical activity of an isolated human islet received 5 from an infant donor. Low frequency spiking 
of an islet during the application of 10 mM glucose and tolbutamide (left) and suppression of spike activity by diazoxide (right). c Glucose-induced insulin 
secretion from adult human islets. All values are shown as filled triangels, the bars indicate means ± SEM. d Oscillatory activity of an islet evoked by 10 mM 
glucose. The islet was within a pancreatic slice placed on a MEA. e Effect of TTX application on oscillatory activity of a human islet in the presence of 10 mM 
glucose and 100 µM tolbutamide. f Lack of effect of TTX on burst activity of a murine islet in the presence of 10 mM glucose.
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(250 µM) which hyperpolarized the cells via the opening of KATP 
channels.  ●▶ Fig. 1d demonstrates that electrical activity can 
even be obtained from a pancreatic slice of a child with CHI. 
Burst activity was measured in 10 mM glucose.
Insulin secretion was measured in batches of adult human islets 
( ●▶ Fig. 1c, islets of the same patient as in  ●▶ Fig. 1a). The islets 
secreted only a small percentage of the stored insulin which was 
less than 0.06 % of 10.0 ± 1.6 µU/10 islets (n = 7) and glucose-
induced insulin secretion did not become significant reflecting a 
low responsiveness of this preparation to glucose.
As reported by Braun et al. [6] gating of voltage-dependent Na +  
channels plays a prominent role in electrical activity of human 
islets.  ●▶ Fig. 1e shows an islet bursting in the presence of 10 mM 
glucose and tolbutamide (100 µM). This bursting activity was 
largely and reversibly diminished by the Na +  channel blocker 
tetrodotoxin (TTX, 300 nM). Braun and co-workers [6] showed 
that TTX (300 nM) applied to human islets reduced the AP 
amplitude by only 25 %, when recorded intracellularly. Further-
more, insulin secretion was reduced by about 50 %, but not abol-
ished [6]. In line with this, we observed bursts of low amplitude 
in the presence of TTX which we ascribe to Ca2 +  APs. Measured 
with extracellular electrodes lower amplitude of the voltage 
deflections does not necessarily mean that the AP amplitude 
itself is smaller, but the upstroke of the AP may be much slower 
matching the differences between voltage-dependent Na +  (fast 
upstroke) and L-type Ca2 +  channels (slow upstroke). In contrast 
to human islets, TTX did not influence glucose-induced bursts of 
mouse islets (n = 9) ( ●▶ Fig. 1f). This is in line with findings by 
Plant [10] who showed that Na +  channels of mouse beta-cells 
are not functional at physiological potentials.
In conclusion, the MEA method emerges as a fast technique for 
the evaluation of glucose responsiveness of single human islets 
or islets in tissue slices. Thus, the MEA technique can increase 
the success rate of experiments in vitro which is very important 
due to limited access to human biopsies and the low number of 
islets in a biopsy. As we have already demonstrated the feasibil-
ity to cultivate mouse islets for long-term recordings on MEAs 
[3], this technique will also pave the way for long-term in vitro 
investigations of human islets.
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